Free AccessOther

Tools

Facebook
Twitter
Linked In
Mendeley
Reddit

Free AccessOther

Triggering Myocardial Infarction by Marijuana

Murray A. Mittleman

Murray A. Mittleman

From the Institute for the Prevention of Cardiovascular Disease, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (M.A.M., R.A.L.); the Department of Epidemiology (M.A.M., M.M.) and the Department of Health and Social Behavior (J.B.S.), Harvard School of Public Health; and the Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School (J.E.M.), Boston, Mass.

Search for more papers by this author

Rebecca A. Lewis

Rebecca A. Lewis

Search for more papers by this author

Malcolm Maclure

Malcolm Maclure

Search for more papers by this author

Jane B. Sherwood

Jane B. Sherwood

Search for more papers by this author

and

James E. Muller

James E. Muller

Search for more papers by this author

Originally published12 Jun 2001https://doi.org/10.1161/01.CIR.103.23.2805Circulation. 2001;103:2805–2809

Abstract

Background—Marijuana use in the age group prone to coronary artery disease is higher than it was in the past. Smoking marijuana is known to have hemodynamic consequences, including a dose-dependent increase in heart rate, supine hypertension, and postural hypotension; however, whether it can trigger the onset of myocardial infarction is unknown.

Methods and Results—In the Determinants of Myocardial Infarction Onset Study, we interviewed 3882 patients (1258 women) with acute myocardial infarction an average of 4 days after infarction onset. We used the case-crossover study design to compare the reported use of marijuana in the hour preceding symptoms of myocardial infarction onset to its expected frequency using self-matched control data. Of the 3882 patients, 124 (3.2%) reported smoking marijuana in the prior year, 37 within 24 hours and 9 within 1 hour of myocardial infarction symptoms. Compared with nonusers, marijuana users were more likely to be men (94% versus 67%, P<0.001), current cigarette smokers (68% versus 32%, P<0.001), and obese (43% versus 32%, P=0.008). They were less likely to have a history of angina (12% versus 25%, P<0.001) or hypertension (30% versus 44%, P=0.002). The risk of myocardial infarction onset was elevated 4.8 times over baseline (95% confidence interval, 2.4 to 9.5) in the 60 minutes after marijuana use. The elevated risk rapidly decreased thereafter.

Conclusions—Smoking marijuana is a rare trigger of acute myocardial infarction. Understanding the mechanism through which marijuana causes infarction may provide insight into the triggering of myocardial infarction by this and other, more common stressors.

Marijuana is the most widely used illicit drug in the United States. In 1998, >72 million Americans, accounting for 33% of the population older than 12 years, had used marijuana or hashish at least once in their lifetime, with 8.6% reporting using the drug in the past year and 5.0% reporting use in the past month.¹ Self-reported use of marijuana is greatest among adults between 18 and 25 years of age.¹ Historically, the prevalence of smoking marijuana was very low among older adults. However, as the generation born in the 20 years after the end of the Second World War ages, the prevalence of marijuana use in the age group prone to coronary artery disease has increased.

Marijuana has several well-described effects on the cardiovascular system. For example, smoking marijuana is associated with a dose-dependent increase in the resting heart rate of 20% to 100%.² ³ ⁴ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁰ Blood pressure is typically increased in the supine position,³ ⁶ ⁷ ⁹ and postural hypotension, which is often symptomatic, is common. Overall, there is a net increase in myocardial oxygen demand with a decrease in oxygen supply, which is due in part to an increase in carboxyhemoglobin³ ; this results in a lower anginal threshold in patients with chronic stable angina.³ ¹¹ Furthermore, there are several reports of myocardial infarction occurring in close proximity to marijuana use in otherwise low-risk individuals.¹² ¹³ ¹⁴

An Institute of Medicine report on marijuana and medicine released in 1999 noted that although the cardiovascular effects of marijuana do not seem to pose a health problem for healthy young users, they may present a serious problem for older subjects.¹⁵ The report also noted that any effect of marijuana use on cardiovascular disease could have a substantial impact on public health. The magnitude of the impact remains to be determined: long-term marijuana users from the late 1960s are now entering the years during which coronary arterial and cerebrovascular diseases become common. The report recommends that “studies to define the individual health risks of smoking marijuana should be conducted, particularly among populations in which marijuana use is prevalent.”¹⁵

To evaluate whether marijuana is a trigger of the onset of an acute myocardial infarction, we collected data on marijuana use in 3882 patients (1258 women) who sustained an acute myocardial infarction and were interviewed for the Determinants of Myocardial Infarction Onset Study.¹⁶ ¹⁷ In this multicenter, interview-based study, we used a case-crossover study design to compare the reported use of marijuana in the hour preceding the onset of myocardial infarction symptoms to its expected frequency using self-matched control data.

Methods

Study Population

Between August 1989 and September 1996, a total of 3882 patients (2624 men and 1258 women aged 20 to 92 years) were interviewed at 64 medical centers a median of 4 days after their myocardial infarction.

Interviewers identified eligible cases by reviewing coronary care unit admission logs and patients’ charts. For inclusion in the study, patients were required to meet all of the following criteria: at least one creatine kinase level above the upper limit of normal for the clinical laboratory performing the test, positive MB isoenzymes, an identifiable onset of pain or other symptoms typical of infarction, and the ability to complete a structured interview. The institutional review board at each participating center approved the protocol, and informed consent was obtained from each patient.

Detailed chart reviews and patient interviews were conducted by research personnel trained as previously described.¹⁶ ¹⁷ ¹⁸ Data were collected on standard demographic variables and risk factors for coronary artery disease. The interview identified the time, place, and quality of myocardial infarction pain and other symptoms, as well as the timing and estimated usual frequency of exposure to potential triggers of myocardial infarction onset during the prior year. In addition, patients were asked if they had smoked marijuana in the year preceding their infarction. Patients who reported smoking marijuana were also asked to report the last time that they had smoked marijuana and their usual frequency of smoking marijuana over the prior year. Patients were also asked to report the timing of exposure to marijuana and other potential triggers for each of the 26 hours preceding the onset of their symptoms.

Study Design

The design of the Onset Study has been described in detail elsewhere.¹⁶ ¹⁷ ¹⁸ ¹⁹ ²⁰ ²¹ In brief, we used a case-crossover study design¹⁶ ¹⁹ ²⁰ ²² to assess the change in the risk of acute myocardial infarction during a brief “hazard period” after exposure to marijuana and other potential triggers of myocardial infarction onset. An important feature of the case-crossover design is that control information for each patient is based on his or her own past exposure experience.¹⁶ ¹⁹ ²⁰ Self-matching results in freedom from confounding by risk factors that are stable over time but often differ between study subjects.

Marijuana use in the hazard period, the 1-hour period immediately preceding the onset of myocardial infarction symptoms, was compared with its expected frequency based on control data obtained from the patients. We used the usual frequency of marijuana use over the year before myocardial infarction to estimate its expected frequency in an average 1-hour period in this patient population.

Statistical Analysis

The analysis of case-crossover data is an application of standard methods for stratified data analysis.¹⁹ ²⁰ ²³ ²⁴ In this analysis, the stratifying variable is the individual patient, as in a crossover experiment. The ratio of the observed exposure frequency in the hazard period to the expected frequency (from the control information) was used to calculate estimates of the odds ratio as a measure of relative risk.¹⁶ ¹⁹ ²⁰ The amount of person-time exposed to marijuana was estimated by multiplying the reported usual annual frequency of exposure by the duration of its hypothesized physiological effect (1 hour). Unexposed person-time was then calculated by subtracting the exposed person-time in hours from the number of hours in a year. The data were analyzed using methods for cohort studies with sparse data in each stratum.¹⁹ ²⁰ ²⁵

Sensitivity Analyses

To evaluate whether exposure to other triggering behaviors could account for the observed effect of smoking marijuana, we conducted a sensitivity analysis excluding patients who smoked marijuana and engaged in other potentially triggering activities in the hour preceding their infarction.

In another sensitivity analysis, we evaluated the timing of marijuana use among the patients who reported smoking it in the 24 hours before the onset of their infarction symptoms. In this analysis, we compared the number of patients who reported smoking marijuana in the hour before symptom onset to the expected number that would arise if smoking marijuana was unrelated to myocardial infarction onset and the frequency of smoking marijuana was evenly distributed over the prior day.

Results

The characteristics of the patients interviewed are presented in Table 1. Of the 3882 patients with myocardial infarction who were interviewed, 124 (3.2%) reported that they had smoked marijuana in the year preceding their myocardial infarction. The frequency of smoking marijuana was significantly related to age, with 12.5% of patients younger than 50 years reporting smoking marijuana in the past year. The mean age of users was 44±8 years, compared with 62±13 years for nonusers (P<0.001). Compared with nonusers, patients who smoked marijuana were more likely to be men (94% versus 67%, P<0.001), current cigarette smokers (68% versus 32%, P<0.001), and obese (43% versus 32%, P=0.008). They were less likely to have a history of angina (12% versus 25%, P<0.001) or hypertension (30% versus 44%, P=0.002).

Table 2 shows the distribution of the usual frequency of marijuana use among the 124 patients who reported smoking marijuana in the year before their myocardial infarction. The majority of patients who smoked marijuana reported using it at least once per month (67.7%), with 41.2% smoking marijuana at least weekly.

Of the 124 patients who reported smoking marijuana, 37 reported smoking it within 24 hours of myocardial infarction onset and 9 reported use within 1 hour of myocardial infarction symptom onset. In addition to these 9 patients, 3 patients reported using marijuana between 60 and 120 minutes before the onset of symptoms. Of the 37 patients who reported smoking marijuana within 24 hours of myocardial infarction symptoms, only 5 reported smoking it once per month or less, and 28 (76%) reported smoking it at least weekly. Similarly, 7 of the 9 patients (78%) who reported smoking marijuana within 1 hour of symptom onset reported smoking it at least once per week.

On the basis of a case-crossover analysis that controlled for differences between patients, we found that within 1 hour after smoking marijuana, the risk of myocardial infarction onset was elevated 4.8-fold (95% confidence interval, 2.9 to 9.5; P<0.001) compared with periods of nonuse. In the second hour after smoking, the relative risk was 1.7 (95% confidence interval, 0.6 to 5.1; P=0.34), suggesting a rapid decline in the cardiac effects of marijuana (Figure).

A total of 3 patients who smoked marijuana in the hour before their infarction also engaged in other triggering behaviors that hour. One patient reported using cocaine in addition to smoking marijuana, another reported sexual intercourse, and a third patient reported both sexual intercourse and cocaine use. None of the patients who smoked marijuana in the period 1 to 2 hours before their myocardial infarction reported exposure to other known triggers in that hour. A sensitivity analysis excluding these 3 patients resulted in a relative risk of 3.2 (95% confidence interval, 1.4 to 7.3; P=0.007) for smoking marijuana in the absence of other potential triggers of myocardial infarction.

In another sensitivity analysis, we evaluated the timing of marijuana use among the 37 patients who reported smoking it in the 24 hours before the onset of their infarction symptoms. If smoking marijuana was unrelated to myocardial infarction onset, we would expect these 37 cases to be evenly distributed over the 24-hour period. This sensitivity analysis resulted in a relative risk of 5.8 (95% confidence interval, 2.8 to 12.1).

Because of the small number of exposed cases, we were unable to evaluate whether the risk of having a myocardial infarction associated with smoking marijuana differed in subsets of patients.

Discussion

In the present study, we observed that smoking marijuana was a rare trigger of acute myocardial infarction. The risk of myocardial infarction onset was elevated almost 5-fold in the hour after smoking marijuana and persisted after excluding patients who also engaged in other potentially triggering exposures in that hour. The heightened risk seemed to decline rapidly and was not significantly elevated beyond the first hour. Overall, the use of marijuana among patients in the Onset Study was quite low, consistent with national survey data.¹ Only 3.2% of patients reported smoking marijuana in the year before their infarction. However, among patients younger than 50 years, marijuana smoking was much more common, with 12.5% of patients reporting smoking it.

The elevation in the risk of myocardial infarction in the hour after marijuana use that we observed was much smaller than the risk previously reported for cocaine,¹⁷ which unlike marijuana is associated with a marked increase in sympathetic stimulation. We have previously reported that cocaine is associated with a nearly 24-fold increase in the risk of myocardial infarction onset in the hour after use.¹⁷

Biological Effects of Marijuana

The effects of cannabinoids are primarily mediated by the activation of cannabinoid receptors, which are present in a variety of tissues including the brain (basal ganglia, substantia nigra pars reticulata, entopeduncular nucleus, globus pallidus, putamen, cerebellum, hippocampus, and cerebral cortex) and cells of the immune system, spleen, blood vessels, and the heart.¹⁵ ²⁶ The cannabinoid receptors are part of the family of G protein–coupled receptors. Two main subtypes of cannabinoid receptors have been identified and cloned (CB1 and CB2), and a naturally occurring agonist, anandamide, has been identified. In addition to these receptors, Jarai and colleagues²⁶ recently identified cannabinoid-induced mesenteric vasodilatation through an endothelial site distinct from CB1 or CB2 receptors.

However, the biological effects of smoked marijuana are complex. In addition to the effects of delta-9-tetrahydrocannabinol and other cannabinoids, smoking marijuana is also associated with exposure to particulates and gaseous material arising from the combustion of plant products. In addition, it is not uncommon for marijuana and, more commonly, other cannabinoids such as hashish to be mixed with tobacco.

Several effects of smoked marijuana on the cardiovascular system have been well described. For example, smoking marijuana is associated with a dose-dependent increase in heart rate.² ³ ⁴ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁰ Although there is much interindividual variability, typical increases in heart rate associated with a single marijuana cigarette range from 20% to 100%, with the peak in heart rate occurring 10 to 30 minutes after beginning to smoke.² ⁴ ⁶ ⁷ ⁸ In addition, most subjects experience an increase in blood pressure, particularly when supine.³ ⁶ ⁷ ⁹ Postural hypotension after smoking marijuana is not uncommon.⁵ ⁹ ²⁷ Tolerance to the hemodynamic effects of marijuana can occur with frequent repeated use.²⁷ ²⁸

In addition to the hemodynamic effects, smoked marijuana is associated with an increase in carboxyhemoglobin, resulting in decreased oxygen-carrying capacity.³ ⁵ ¹¹ Whether marijuana affects the hemostatic balance is unclear. Marijuana may increase factor VII activity; however, there are mixed results in terms of the effects of smoked marijuana on platelet function.²⁹ Thus, taken together, smoking marijuana is associated with an increase in myocardial oxygen demand and a concomitant decrease in oxygen supply.

Aronow and Cassidy³ ¹¹ demonstrated that among patients with chronic stable angina, the anginal threshold is acutely diminished after smoking a single marijuana cigarette. In particular, the exercise time to angina was decreased by an average of 48% after smoking a single marijuana cigarette, compared with an 8.6% decrease after smoking a marijuana placebo (marijuana cigarette with no delta-9-tetrahydrocannabinol) and a 23% decrease after smoking a high nicotine tobacco cigarette.³ ¹¹

Thus, some marijuana-associated infarctions may be caused by a myocardial oxygen supply that is inadequate to cope with the increased oxygen demands that occur as result of smoking marijuana. However, the culprit lesion in a majority of myocardial infarctions occurs at the site of a disrupted atherosclerotic plaque.³⁰ ³¹ A proposed mechanism for the triggering of myocardial infarction is that onset occurs when a vulnerable, but not necessarily stenotic, atherosclerotic plaque is disrupted in response to hemodynamic stresses; thereafter, hemostatic and vasoconstrictive forces determine whether the resultant thrombus becomes occlusive.³² ³³ Whether the direct or indirect hemodynamic effects of marijuana are sufficient to cause plaque disruption is speculative, because there are no direct studies of this phenomenon available in the literature.

Limitations

The present study has several potential limitations. Because the data are based on patient self-report, some misclassification of exposure is likely to have occurred. For example, patients may be reluctant to report that they had used marijuana before their myocardial infarction. The effect of such a bias would reduce the magnitude of the estimated relative risk. In an effort to minimize such reporting bias and to maintain patient confidentiality, efforts were made to ensure the patient’s privacy during the interview. Furthermore, to obtain comparable reporting of marijuana smoking for all of the hourly intervals during the day preceding the infarction, patients were not informed of the duration of the hypothesized hazard period.

There is a possibility of bias caused by differential survival of cases who had their myocardial infarction triggered by different mechanisms. For example, if patients whose infarctions were triggered by marijuana were more likely to die than those whose infarctions were unrelated to marijuana, then the apparent relative risk may be underestimated.

However, it is possible that patients under-report long-term use of marijuana because of the social stigma attached to it, but they may be relatively accurate about its use on the day of their myocardial infarction because of potential clinical benefit. This may result in an overestimate of the relative risk. However, the sensitivity analysis restricted to the 37 patients who reported smoking marijuana within 24 hours of the onset of myocardial infarction symptoms resulted in a relative risk of 5.8, which is similar to the result based on all patients who reported smoking marijuana in the prior year.

In traditional epidemiological studies of coronary heart disease, confounding by differences in risk factors between individuals is a major threat to validity. A strength of the case-crossover design used in this study is that self-matching ensures that within strata, there is no variability in traditional chronic risk factors for coronary heart disease. Thus, by design, confounding by all traditional chronic risk factors for coronary heart disease, whether measured or unmeasured, is controlled for in the analysis.¹⁹ ²⁴

A limitation of the case-crossover design used in this study is that, like case-control studies, the absolute risk of myocardial infarction onset cannot be directly estimated from the data. However, an estimate of the baseline risk can be made using other data sources. For example, on the basis of the Framingham Heart Study risk equation,³⁴ ³⁵ the baseline risk of acute myocardial infarction for a typical marijuana user in this study (44-year-old male smoker with average levels of other risk factors) is between 1 and 1.5 per million per hour. Thus, in the hour after marijuana use, the absolute risk would increase to ≈7 per million per hour. For a daily user of marijuana, the risk would accumulate over the course of time, leading to an annual excess risk of an acute cardiovascular event of ≈1.5% to 3% per year. Furthermore, for high-risk patients with either multiple risk factors or established coronary artery disease, the risk may be substantially higher.

In summary, smoking marijuana is a rare trigger of acute myocardial infarction and may pose a health risk to patients with established coronary artery disease and perhaps to individuals with multiple coronary risk factors. Understanding the mechanism by which marijuana causes infarction may provide insight into the triggering of myocardial infarction by this and other, more common stressors.

**Figure 1.** Relative risk of myocardial infarction onset after smoking marijuana. The relative risk of myocardial infarction onset is plotted on a logarithmic scale for each of the 2 hours after smoking marijuana. Relative risks were estimated by comparing the frequency of marijuana use in each of the 2 hours before myocardial infarction onset to its expected frequency on the basis of each patient’s reported usual frequency of smoking marijuana over the prior year. Error bars indicate 95% confidence intervals. The dotted line represents the baseline risk during periods with no exposure to marijuana.

**Table 1.** Characteristics of the Study Population
Characteristic	Marijuana Users (n=124)	Marijuana Abstainers (n=3758)	P
Age
Mean±SD	43.7±8.0	62.0±12.5	<0.001
<50	96 (77)	672 (18)
50–69	28 (23)	1952 (52)	<0.001
70+	0 (0)	1134 (30)
Sex
Male	116 (94)	2508 (67)
Female	8 (6)	1250 (33)	<0.001
Member of a minority group	28 (23)	495 (13)	0.003
Medical history
Prior MI	29 (23)	1038 (28)	0.30
Prior angina	15 (12)	935 (25)	<0.001
Hypertension	37 (30)	1659 (44)	0.002
Diabetes mellitus	9 (7)	723 (19)	<0.001
Obese¹	53 (43)	1184 (32)	0.008
Current smoker	84 (68)	1196 (32)	<0.001
Medication use before MI
Aspirin	43 (35)	1414 (38)	0.51
Calcium channel blockers	16 (13)	911 (24)	0.004
β-blockers	16 (13)	817 (22)	0.02
ACE inhibitors	10 (8)	505 (13)	0.08

Values are n (%) unless otherwise indicated. MI indicates myocardial infarction; ACE, angiotensin-converting enzyme.

¹Obesity was defined as a body mass index >29 kg/m.

**Table 2.** Usual Frequency of Marijuana Smoking Among 124 Patients Who Reported Using Marijuana in the Year Before Myocardial Infarction
Usual Frequency of Smoking Marijuana	n (%)
At least daily	22 (17.7)
≥1 per week and <1 per day	30 (24.2)
≥1 per month and <1 per week	32 (25.8)
Less than once a month	40 (32.3)

This work was supported by grants from the National Heart, Lung, and Blood Institute (HL41016) and the American Heart Association (9630115N). We are grateful to the Onset Study interviewers for their dedication and to Kate Dwyer, BS, and Diane Walkoff, BS, for their expert assistance in conducting the Onset Study.

Footnotes

Correspondence to Murray A. Mittleman, MD, DrPH, Cardiovascular Division, Beth Israel Deaconess Medical Center, 1 Autumn Street, Fifth Floor, Boston, MA 02215. E-mail [email protected]

References

1 Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse. Rockville, Md: SAMHSA, Office of Applied Sciences; 1998. DHHS No. (SMA)99–3328 1999.Google Scholar
2 Renault PF, Schuster CR, Heinrich R, et al. Marihuana. standardized smoke administration and dose effect curves on heart rate in humans. Science.1971; 174:589–591.Crossref Medline Google Scholar
3 Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med.1974; 291:65–67.Crossref Medline Google Scholar
4 Clark SC, Greene C, Karr GW, et al. Cardiovascular effects of marihuana in man. Can J Physiol Pharmacol.1974; 52:706–719.Crossref Medline Google Scholar
5 Hollister LE. Health aspects of cannabis. Pharmacol Rev.1986; 38:1–20.Medline Google Scholar
6 Johnson S, Domino EF. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther.1971; 12:762–768.Crossref Medline Google Scholar
7 Roth WT, Tinkleinberg JR, Kopell BS, et al. Continuous electrocardiographic monitoring during marihuana intoxication. Clin Pharmacol Ther.1973; 14:533–540.Crossref Medline Google Scholar
8 Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking: cardiovascular effects in man and possible mechanisms. N Engl J Med.1972; 287:209–212.Crossref Medline Google Scholar
9 Weiss JL, Watanabe AM, Lemberger L, et al. Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther.1972; 13:671–684.Crossref Medline Google Scholar
10 Hollister LE. Cannabis: 1988. Acta Psychiatr Scand Suppl.1988; 345:108–118.Medline Google Scholar
11 Aronow WS, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther.1975; 17:549–554.Crossref Medline Google Scholar
12 Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol.1979; 14:433–438.Crossref Medline Google Scholar
13 Collins JS, Higginson JD, Boyle DM, et al. Myocardial infarction during marijuana smoking in a young female. Eur Heart J.1985; 6:637–638.Crossref Medline Google Scholar
14 Pearl W, Choi YS. Marijuana as a cause of myocardial infarction. Int J Cardiol.1992; 34:353.Crossref Medline Google Scholar
15 Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press; 1999.Google Scholar
16 Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial infarction by heavy exertion: protection against triggering by regular exertion. N Engl J Med.1993; 329:1677–1683.Crossref Medline Google Scholar
17 Mittleman MA, Mintzer D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation.1999; 99:2737–2741.Crossref Medline Google Scholar
18 Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of myocardial infarction by episodes of anger. Circulation.1995; 92:1720–1725.Crossref Medline Google Scholar
19 Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol.1991; 133:144–153.Crossref Medline Google Scholar
20 Mittleman MA, Maclure M, Robins JM. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. Am J Epidemiol.1995; 142:91–98.Crossref Medline Google Scholar
21 Muller JE, Mittleman MA, Maclure M, et al. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular exertion. JAMA.1996; 275:1405–1409.Crossref Medline Google Scholar
22 Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health.2000; 21:193–221.Crossref Medline Google Scholar
23 Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown and Company; 1986.Google Scholar
24 Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of controls in case-control studies. Am J Epidemiol.1992; 135:1019–1028.Crossref Medline Google Scholar
25 Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics.1985; 41:55–68.Crossref Medline Google Scholar
26 Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A.1999; 96:14136–14141.Crossref Medline Google Scholar
27 Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther.1975; 18:287–297.Crossref Medline Google Scholar
28 Jones RT, Benowitz N, Bachman J. Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci.1976; 282:221–239.Crossref Medline Google Scholar
29 Heiden D, Rodvien R, Jones R, et al. Effect of oral delta-9-tetrahydrocannabinol on coagulation. Thromb Res.1980; 17:885–889.Crossref Medline Google Scholar
30 Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J.1985; 53:363–373.Crossref Medline Google Scholar
31 Fuster V, Lewis A. Conner memorial lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation.1994; 90:2126–2146.Crossref Medline Google Scholar
32 Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation.1989; 79:733–743.Crossref Medline Google Scholar
33 Muller JE, Abela GS, Nesto RW, et al. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol.1994; 23:809–813.Crossref Medline Google Scholar
34 Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J.1993; 121:293–298.Google Scholar
35 Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation.1991; 83:356–362. Crossref Medline Google Scholar

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Cited By

Mondal A, Dadana S, Parmar P, Mylavarapu M, Dong Q, Butt S, Kali A, Bollu B and Desai R (2024) Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis, Medical Sciences, 10.3390/medsci12010013, 12:1, (13)

Vgontzas A (2024) Examining substance use patterns in adults with migraine: A changing landscape, Headache: The Journal of Head and Face Pain, 10.1111/head.14660, 64:2, (129-130), Online publication date: 1-Feb-2024.

Padda I, Mahtani A, Farid M, Fabian D, Nigussie B, Piccione G, Kavarthapu A, Sethi Y and Htyte N (2024) Marijuana-induced ST-elevation myocardial infarction in adolescents and young adults: A case report and comprehensive review of literature, Current Problems in Cardiology, 10.1016/j.cpcardiol.2023.102225, 49:2, (102225), Online publication date: 1-Feb-2024.

Ye I and Hines G (2024) Marijuana and Vascular Disease: A Review, Cardiology in Review, 10.1097/CRD.0000000000000649

Lee B, Sideris A, Ladha K, Johnson R and Wu C (2023) Cannabis and Cannabinoids in the Perioperative Period, Anesthesia & Analgesia, 10.1213/ANE.0000000000006070, 138:1, (16-30), Online publication date: 1-Jan-2024.

Barbonetti A, Rastrelli G, Sparano C, Castellini C, Vignozzi L, Maggi M and Corona G (2023) Is marijuana a foe of male sexuality? Data from a large cohort of men with sexual dysfunction, Andrology, 10.1111/andr.13382, 12:1, (9-19), Online publication date: 1-Jan-2024.

Van Halm-Lutterodt N, Albright J, Storlie N, Mesregah M, Ansari K, Balmaceno-Criss M, Daher M, Bartels-Mensah M, Xu Y, Diebo B, Hai Y, Chandler D and Daniels A (2024) Cannabis use Disorder and Complications After Anterior Cervical Diskectomy and Fusion, World Neurosurgery, 10.1016/j.wneu.2023.11.028, 181, (e1001-e1011), Online publication date: 1-Jan-2024.

Rorabaugh B, Guindon J and Morgan D (2023) Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury, Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.123.001665, 387:3, (265-276), Online publication date: 1-Dec-2023.

Az A (2023) Jellybean-Induced Intoxication, American Journal of Forensic Medicine & Pathology, 10.1097/PAF.0000000000000858, 44:4, (358-361), Online publication date: 1-Dec-2023.

Tuvel A, Winiger E and Ross J (2023) A Review of the Effects of Adolescent Cannabis Use on Physical Health, Psychiatric Clinics of North America, 10.1016/j.psc.2023.03.005, 46:4, (719-739), Online publication date: 1-Dec-2023.

Bailey B, Dimas M, Oechslin E, Soldevilla S and Styra R (2023) Cannabis Use: A New Risk Behaviour Among Adults With Congenital Heart Disease, CJC Pediatric and Congenital Heart Disease, 10.1016/j.cjcpc.2023.09.001, 2:6, (484-489), Online publication date: 1-Dec-2023.

Demina A, Cottin Y, Chagué F, Bentounes S, Bichat F, Genet T, Vigny P, Zeller M and Fauchier L (2023) History of illicit drug use in adults with acute myocardial infarction: Temporal trends from the French national hospital discharge database, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2023.09.002, 116:12, (597-601), Online publication date: 1-Dec-2023.

Tsvetkova D, Peykova L, Andonova-Dimitrova L and Pencheva I (2023) Regulation and control of the use of Cannabis and Cannabidiol in „novel foods”, Pharmacia, 10.3897/pharmacia.70.e114938, 70:4, (1385-1395)

Gabarin A, Yarmolinsky L, Budovsky A, Khalfin B and Ben-Shabat S (2023) Cannabis as a Source of Approved Drugs: A New Look at an Old Problem, Molecules, 10.3390/molecules28237686, 28:23, (7686)

Clement A, Pezel T, Lequipar A, Guiraud-Chaumeil P, Singh M, Poinsignon H, El Beze N, Gall E, Goncalves T, Lafont A, Henry P and Dillinger J (2023) Consommation de drogues récréatives et pathologies cardiovasculaires, Annales de Cardiologie et d'Angéiologie, 10.1016/j.ancard.2023.101638, 72:5, (101638), Online publication date: 1-Nov-2023.

Paul C, Charlotte M, Isabelle E, de la Grandmaison Geoffroy L and Jean-Claude A (2023) Evaluation of the cardiovascular risk induced by cannabis use from a series of 43 autopsy cases, International Journal of Legal Medicine, 10.1007/s00414-023-03079-x, 137:6, (1725-1733), Online publication date: 1-Nov-2023.

Gillett L, Johnson-Sasso C, Miller B, Shakowski C, Walker L and Tompkins C (2023) Arrhythmic Effects of Cannabis in Ischemic Heart Disease, Cannabis and Cannabinoid Research, 10.1089/can.2021.0188, 8:5, (867-876), Online publication date: 1-Oct-2023.

Corroon J, Grant I, Allison M and Bradley R (2023) Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018, The American Journal of Cardiology, 10.1016/j.amjcard.2023.07.065, 204, (226-233), Online publication date: 1-Oct-2023.

Pombeiro Stein I, Fricke T and Leffler A (2023) Hat medizinisches Cannabis oder Cannabiskonsum einen Einfluss auf das perioperative anästhesiologische Management?Does medicinal cannabis or cannabis consumption have an influence on the perioperative anesthesiological management?, Die Anaesthesiologie, 10.1007/s00101-023-01314-z, 72:9, (621-626), Online publication date: 1-Sep-2023.

Arshad H, Mousa A, Oudah B, Kakhktsyan T, Abu-Abaa M and Kass R Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report, Cureus, 10.7759/cureus.39594

Iftikhar H, Saleem M, Naeem H and Fatima D Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review, Cureus, 10.7759/cureus.39236

Amaral C, Carvalho C, Scaranelo A, Chapman K, Chatkin J and Ferreira I (2023) Cannabis and sleep disorders: not ready for prime time? A qualitative scoping review, Journal of Clinical Sleep Medicine, 10.5664/jcsm.10428, 19:5, (975-990), Online publication date: 1-May-2023.

Vallée A (2023) Association between cannabis use and ten-year estimated atherosclerotic cardiovascular disease risk in a middle-aged population survey, European Journal of Internal Medicine, 10.1016/j.ejim.2023.02.020, 111, (69-76), Online publication date: 1-May-2023.

Khan M, Khan F, Khan H and Brabham D Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest, Cureus, 10.7759/cureus.38026

Han B, Brennan J, Orozco M, Moore A and Castillo E (2023) Trends in emergency department visits associated with cannabis use among older adults in California, 2005–2019, Journal of the American Geriatrics Society, 10.1111/jgs.18180, 71:4, (1267-1274), Online publication date: 1-Apr-2023.

Vallée A (2023) Association between lifetime cannabis use and arterial stiffness in a middle-aged general population, Journal of Hypertension, 10.1097/HJH.0000000000003389, 41:4, (658-669), Online publication date: 1-Apr-2023.

Shah S, Schwenk E, Sondekoppam R, Clarke H, Zakowski M, Rzasa-Lynn R, Yeung B, Nicholson K, Schwartz G, Hooten W, Wallace M, Viscusi E and Narouze S (2023) ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids, Regional Anesthesia & Pain Medicine, 10.1136/rapm-2022-104013, 48:3, (97-117), Online publication date: 1-Mar-2023.

Sandhyavenu H, Patel H, Patel R, Desai R, Patel A, Patel B, Patel J, Zahid S, Khan S, Deshmukh A, Nasir K, DeSimone C, Dani S and Thakkar S (2023) Rising trend of acute myocardial infarction among young cannabis users: A 10-year nationwide gender and race stratified analysis, International Journal of Cardiology Cardiovascular Risk and Prevention, 10.1016/j.ijcrp.2022.200167, 16, (200167), Online publication date: 1-Mar-2023.

Ahrens E, Wachtendorf L, Chiarella L, Ashrafian S, Suleiman A, Tartler T, Azizi B, Chen G, Berger A, Shay D, Teja B, Banner-Goodspeed V, Ma H, Eikermann M, Hill K and Schaefer M (2023) Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study, eClinicalMedicine, 10.1016/j.eclinm.2023.101831, 57, (101831), Online publication date: 1-Mar-2023.

Vallée A (2023) Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status, Scientific Reports, 10.1038/s41598-022-22841-6, 13:1

Matei D, Trofin D, Iordan D, Onu I, Condurache I, Ionite C and Buculei I (2023) The Endocannabinoid System and Physical Exercise, International Journal of Molecular Sciences, 10.3390/ijms24031989, 24:3, (1989)

Nway N, Pandey S, Chowdhury T, Shankar M and Panigrahi K A Case Report of Cannabis Abuse: A Surprising Etiology of Elevated Troponin, Cureus, 10.7759/cureus.33423

Britch S, Walsh S, Vickers-Smith R, Babalonis S and Slavova S (2022) Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019, Substance Use & Misuse, 10.1080/10826084.2022.2148478, 58:1, (66-76), Online publication date: 2-Jan-2023.

Theerasuwipakorn N, Prechawat S, Chokesuwattanaskul R, Siranart N, Marsukjai A, Thumtecho S and Rungpradubvong V (2023) Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies, Toxicology Reports, 10.1016/j.toxrep.2023.04.011, 10, (537-543), .

Tuvel A, Winiger E and Ross J (2023) A Review of the Effects of Adolescent Cannabis Use on Physical Health, Child and Adolescent Psychiatric Clinics of North America, 10.1016/j.chc.2022.07.005, 32:1, (85-105), Online publication date: 1-Jan-2023.

Bouquet E, Jouanjus E and Lapeyre-Mestre M (2023) Recreational cannabis use: French perspective of adverse effects Cannabis Use, Neurobiology, Psychology, and Treatment, 10.1016/B978-0-323-89862-1.00043-X, (127-138), .

Power A and Dipchand A (2023) Pediatric Heart Transplantation Pediatric Cardiology, 10.1007/978-3-030-42937-9_83-1, (1-27), .

Cheung C, Nardone M, Lee J, Baker R, Millar P and Burr J (2022) Cannabis Inhalation Acutely Reduces Muscle Sympathetic Nerve Activity in Humans, Circulation, 146:25, (1972-1974), Online publication date: 20-Dec-2022.

Shah J and Fermo O (2022) Review of systemic and syndromic complications of cannabis use: A review, Medicine, 10.1097/MD.0000000000032111, 101:49, (e32111), Online publication date: 9-Dec-2022.

Singla S and Block R (2022) Effect Compartment Model for the Evaluation of Tolerance to Psychological Highness Following Smoking Marijuana, The Journal of Clinical Pharmacology, 10.1002/jcph.2109, 62:12, (1539-1547), Online publication date: 1-Dec-2022.

Doolub G, Kandoole-Kabwere V and Felekos I (2021) Acute Coronary Syndromes Due to Atherosclerotic Coronary Artery Disease in Young Patients, Cardiology in Review, 10.1097/CRD.0000000000000402, 30:6, (286-292), Online publication date: 1-Nov-2022.

Rosa G, Puce L, Mori L, Currà A, Fattapposta F, Porto I, Bragazzi N, Trompetto C and Marinelli L (2022) Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.990188, 9

Wiliński J, Skwarek A, Chrzan I, Zeliaś A, Borek R, Dykla D, Bober-Fotopoulos M and Dudek D (2022) Paroxysmal Sustained Ventricular Tachycardia with Cardiac Arrest and Myocardial Infarction in 29-Year-Old Man Addicted to Medical Marijuana—It Never Rains but It Pours, Healthcare, 10.3390/healthcare10102024, 10:10, (2024)

Chen M, Lu Y, Chen X, Wang Z and Ma L (2022) Association of cannabis use disorder with cardiovascular diseases: A two-sample Mendelian randomization study, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.966707, 9

Jafry A, LaGrow A, Akhtar K, Hacker E, Russell S, Kliewer B and Asad Z (2022) Synthetic cannabinoids and ST elevation myocardial infarction, The American Journal of the Medical Sciences, 10.1016/j.amjms.2022.05.001, 364:4, (481-491), Online publication date: 1-Oct-2022.

Middlekauff H, Cooper Z and Strauss S (2022) Drugs of Misuse: Focus on Vascular Dysfunction, Canadian Journal of Cardiology, 10.1016/j.cjca.2022.04.011, 38:9, (1364-1377), Online publication date: 1-Sep-2022.

Lavender I, McGregor I, Suraev A, Grunstein R and Hoyos C (2022) Cannabinoids, Insomnia, and Other Sleep Disorders, Chest, 10.1016/j.chest.2022.04.151, 162:2, (452-465), Online publication date: 1-Aug-2022.

Harding B, Austin T, Floyd J, Smith B, Szklo M and Heckbert S (2022) Self-reported marijuana use and cardiac arrhythmias (from the Multiethnic Study of Atherosclerosis), The American Journal of Cardiology, 10.1016/j.amjcard.2022.05.004, 177, (48-52), Online publication date: 1-Aug-2022.

Chelikam N, Vyas V, Dondapati L, Iskander B, Patel G, Jain S, Singla T, Bombaywala A, Zarrate D, Debnath N, Jain N, Peela A, Patel U and Sharma A Epidemiology, Burden, and Association of Substance Abuse Amongst Patients With Cardiovascular Disorders: National Cross-Sectional Survey Study, Cureus, 10.7759/cureus.27016

McGuinness B, Goel A, Chen J, Szalay D, Ladha K, Mittleman M and Harlock J (2022) The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia, Vascular and Endovascular Surgery, 10.1177/15385744221085382, 56:5, (480-494), Online publication date: 1-Jul-2022.

Jakob J, Stalder O, Kali T, Pruvot E, Pletcher M, Rana J, Sidney S and Auer R (2022) The Coronary Artery Risk Development in Young Adults (CARDIA) Study, The American Journal of Medicine, 10.1016/j.amjmed.2022.01.057, 135:7, (871-878.e14), Online publication date: 1-Jul-2022.

Khayat W and Lehmann C (2022) The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies, Metabolites, 10.3390/metabo12060541, 12:6, (541)

Fatmi S and Outlaw A Coronary Vasospasm Associated With Synthetic Marijuana Resulting in Transient Electrocardiogram Changes and Troponin Elevation, Cureus, 10.7759/cureus.25084

Vernail V, Bingaman S, Silberman Y, Raup-Konsavage W, Vrana K and Arnold A (2022) Acute Cannabigerol Administration Lowers Blood Pressure in Mice, Frontiers in Physiology, 10.3389/fphys.2022.871962, 13

Bisch A, Ceelen M, Dorn T, Reijnders U, van den Hondel K, Stomp J, Burger J and Franssen E (2022) Performance of an on-site urine multidrug test used by forensic physicians in determining the cause of death, Journal of Forensic and Legal Medicine, 10.1016/j.jflm.2022.102346, 88, (102346), Online publication date: 1-May-2022.

Flormann D, Qiao M, Murciano N, Iacono G, Darras A, Hof S, Recktenwald S, Rotordam M, Becker N, Geisel J, Wagner C, von Lindern M, van den Akker E and Kaestner L (2022) Transient receptor potential channel vanilloid type 2 in red cells of cannabis consumer, American Journal of Hematology, 10.1002/ajh.26509, 97:5, Online publication date: 1-May-2022.

Testai F, Gorelick P, Aparicio H, Filbey F, Gonzalez R, Gottesman R, Melis M, Piano M, Rubino T and Song S (2022) Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association, Stroke, 53:4, (e176-e187), Online publication date: 1-Apr-2022.

Mani A, Viswanatha K and Harikrishnan S (2022) A rare case of Marijuana use and myocardial infarction: Imaging saves the day, IHJ Cardiovascular Case Reports (CVCR), 10.1016/j.ihjccr.2022.04.002, 6:2, (107-111), Online publication date: 1-Apr-2022.

Helcman M and Šmejkal K (2021) Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases, Phytochemistry Reviews, 10.1007/s11101-021-09777-x, 21:2, (429-470), Online publication date: 1-Apr-2022.

Kopustinskiene D, Masteikova R, Lazauskas R and Bernatoniene J (2022) Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation, Antioxidants, 10.3390/antiox11040660, 11:4, (660)

Weresa J, Pędzińska-Betiuk A, Mińczuk K, Malinowska B and Schlicker E (2022) Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?, Cells, 10.3390/cells11071142, 11:7, (1142)

Karki N, Sapkota B, Magar S, Muhammad A, Paudel B, Chernek P, Afshar M, Bhandari M and Bella J Relationship Between Marijuana Use and Hospitalization for Acute Coronary Syndrome, Cureus, 10.7759/cureus.23317

Seif El Dahan K, Machtoub D, Massoud G, Nasser S, Hamam B, Kobeissy F, Zouein F and Eid A Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction, Current Medicinal Chemistry, 10.2174/0929867328666210608144818, 29:11, (1990-2010)

Bhatt D, Lopes R and Harrington R (2022) Diagnosis and Treatment of Acute Coronary Syndromes, JAMA, 10.1001/jama.2022.0358, 327:7, (662), Online publication date: 15-Feb-2022.

Wynne J and Kozuch P (2021) Medical marijuana for inflammatory bowel disease: the highs and lows, Scandinavian Journal of Gastroenterology, 10.1080/00365521.2021.1998604, 57:2, (197-205), Online publication date: 1-Feb-2022.

Maharaj N, Swarath S, Seecheran R, Seecheran V and Seecheran N (2022) Suspected Cannabis Vaping–Induced Pericardial Effusion, Journal of Investigative Medicine High Impact Case Reports, 10.1177/23247096221140251, 10, (232470962211402), Online publication date: 1-Jan-2022.

Yang P, Odom E, Patel R, Loustalot F and Coleman King S (2021) Nonmedical Marijuana Use and Cardiovascular Events: A Systematic Review, Public Health Reports, 10.1177/0033354920988285, 137:1, (62-71), Online publication date: 1-Jan-2022.

Farouji I, Chan K, Battah A, Abed H, DaCosta T, Correia J and Suleiman A (2022) A rare case of marijuana associated with ascending aorta thrombosis complicated with stroke and bilateral renal infarcts, Radiology Case Reports, 10.1016/j.radcr.2021.10.013, 17:1, (119-123), Online publication date: 1-Jan-2022.

Ross J, Ellingson J, Frieser M, Corley R, Hopfer C, Stallings M, Wadsworth S, Reynolds C and Hewitt J (2022) The effects of cannabis use on physical health: A co-twin control study, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2021.109200, 230, (109200), Online publication date: 1-Jan-2022.

Brust J (2022) Stroke and Substance Abuse Stroke, 10.1016/B978-0-323-69424-7.00039-9, (563-572.e15), .

Lau R and Fishbein M (2022) Toxins and the heart Cardiovascular Pathology, 10.1016/B978-0-12-822224-9.00012-8, (535-552), .

Finlayson A and Palatnick W (2022) Complications and Adverse Events from Cannabis Use Cannabis Use in Medicine, 10.1007/978-3-031-12722-9_12, (119-129), .

Bennett J, Butterfield K and Kramer K (2022) Outpatient Anesthesia Peterson’s Principles of Oral and Maxillofacial Surgery, 10.1007/978-3-030-91920-7_4, (81-127), .

Wawrzyniak A, Bekkouche N and Krantz D (2022) Acute Behavioral and Psychosocial Triggers of Myocardial Infarction Handbook of Cardiovascular Behavioral Medicine, 10.1007/978-0-387-85960-6_47, (1131-1148), .

Bär S, Praz F and Räber L (2021) Plaque erosion causing ST-elevation myocardial infarction after consumption of cannabis and N2O in a 27-year old man: a case report, BMC Cardiovascular Disorders, 10.1186/s12872-021-01953-3, 21:1, Online publication date: 1-Dec-2021.

Takakuwa K and Schears R (2021) The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review, International Journal of Emergency Medicine, 10.1186/s12245-021-00330-3, 14:1, Online publication date: 1-Dec-2021.

Hasslacher S, Wichmann C, Meyer M, Kurz D and Eberli F (2021) Myokardinfarkt bei einem Sportler, Praxis, 10.1024/1661-8157/a003745, 110:16, (985-990), Online publication date: 1-Dec-2021.

Kaplan A (2021) Cannabis and Lung Health: Does the Bad Outweigh the Good?, Pulmonary Therapy, 10.1007/s41030-021-00171-8, 7:2, (395-408), Online publication date: 1-Dec-2021.

Wen X, Wang S, Lewkowitz A, Ward K, Brousseau E and Meador K (2021) Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models, Drug Safety, 10.1007/s40264-021-01115-6, 44:12, (1297-1309), Online publication date: 1-Dec-2021.

Dabiri A and Kassab G (2021) Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns, Medical Cannabis and Cannabinoids, 10.1159/000519775, 4:2, (75-85)

Kasuda S, Kondo T, Terazawa I, Morimoto M, Yuui K and Kudo R (2021) Cardiac sudden death in a young cannabis user, Legal Medicine, 10.1016/j.legalmed.2021.101955, 53, (101955), Online publication date: 1-Nov-2021.

Voigt I and Schmitz T (2021) eCPR eines jungen Erwachsenen eCPR in a young adult, Medizinische Klinik - Intensivmedizin und Notfallmedizin, 10.1007/s00063-021-00829-w, 116:8, (708-711), Online publication date: 1-Nov-2021.

Jeffers A, Glantz S, Byers A and Keyhani S (2021) Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US, JAMA Network Open, 10.1001/jamanetworkopen.2021.36571, 4:11, (e2136571)

Shah H, Fraser M, Agdamag A, Maharaj V, Nzemenoh B, Martin C, Alexy T and Garry D (2021) Cardiac Transplantation and the Use of Cannabis, Life, 10.3390/life11101063, 11:10, (1063)

Modi V, Singh A and Shirani J Marijuana Use and Stress Cardiomyopathy in the Young, Cureus, 10.7759/cureus.18575

Shahandeh N, Chowdhary H and Middlekauff H (2021) Vaping and cardiac disease, Heart, 10.1136/heartjnl-2020-318150, 107:19, (1530-1535), Online publication date: 1-Oct-2021.

Han J, So I, Dodson T and Burke A (2021) Do Oral and Maxillofacial Surgeons Prescribe More Opioids After Third Molar Removal for Patients with Substance Use History?, Journal of Oral and Maxillofacial Surgery, 10.1016/j.joms.2021.06.002, 79:10, (2010-2015), Online publication date: 1-Oct-2021.

Bukke V, Archana M, Villani R, Serviddio G and Cassano T (2021) Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health, Pharmaceuticals, 10.3390/ph14100965, 14:10, (965)

Rabino M, Mallia S, Castiglioni E, Rovina D, Pompilio G and Gowran A (2021) The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases, Pharmaceuticals, 10.3390/ph14090936, 14:9, (936)

KEEN L, ABBATE A, CLARK V, MOELLER F and TAN A Differences in heart rate among recent marijuana use groups, Minerva Cardiology and Angiology, 10.23736/S2724-5683.20.05239-1, 69:4

Stasiak A and Kędziora P (2020) Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report, Journal of Paediatrics and Child Health, 10.1111/jpc.15227, 57:9, (1500-1504), Online publication date: 1-Sep-2021.

Haleem A, Hwang Y, Elton‐Marshall T, Rehm J and Imtiaz S (2021) The longitudinal relationship between cannabis use and hypertension, Drug and Alcohol Review, 10.1111/dar.13266, 40:6, (914-919), Online publication date: 1-Sep-2021.

Nafe R, Arendt C and Hattingen E (2021) Cannabis und synthetische Cannabinoide – eine nicht nur radiologische Übersicht, Radiologie up2date, 10.1055/a-1382-7146, 21:03, (227-243), Online publication date: 1-Sep-2021.

Olt C, Faulkenberg K and Hsich E (2021) The growing dilemma of legalized cannabis and heart transplantation, The Journal of Heart and Lung Transplantation, 10.1016/j.healun.2021.03.024, 40:9, (863-871), Online publication date: 1-Sep-2021.

Verma A, Nanda V, Kabi A and Baid H (2021) Marijuana-induced acute myocardial infarction in a young adult male, BMJ Case Reports, 10.1136/bcr-2021-243335, 14:7, (e243335), Online publication date: 1-Jul-2021.

Skipina T, Upadhya B and Soliman E (2021) Cannabis Use and Electrocardiographic Myocardial Injury, The American Journal of Cardiology, 10.1016/j.amjcard.2021.03.058, 151, (100-104), Online publication date: 1-Jul-2021.

Topal L, Naveed M, Orvos P, Pászti B, Prorok J, Bajtel Á, Kiss T, Csupor-Löffler B, Csupor D, Baczkó I, Varró A, Virág L and Jost N (2021) The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations, Archives of Toxicology, 10.1007/s00204-021-03086-0, 95:7, (2497-2505), Online publication date: 1-Jul-2021.

Egée S and Kaestner L (2021) The Transient Receptor Potential Vanilloid Type 2 (TRPV2) Channel–A New Druggable Ca2+ Pathway in Red Cells, Implications for Red Cell Ion Homeostasis, Frontiers in Physiology, 10.3389/fphys.2021.677573, 12

Saeed S, Rotevatn S, Schjøtt J and Larsen T (2021) Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View, Journal of Cardiovascular Development and Disease, 10.3390/jcdd8060067, 8:6, (67)

Chiu R, Patel S, Siddiqui N, Nunna R and Mehta A (2021) Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States, Spine, 10.1097/BRS.0000000000004035, 46:11, (734-743), Online publication date: 1-Jun-2021.

Jakob J, von Wyl R, Stalder O, Pletcher M, Vittinghoff E, Tal K, Rana J, Sidney S, Reis J and Auer R (2021) Cumulative Marijuana Use and Carotid Intima-Media Thickness at Middle Age: The CARDIA Study, The American Journal of Medicine, 10.1016/j.amjmed.2020.11.026, 134:6, (777-787.e9), Online publication date: 1-Jun-2021.

Moustafa B and Testai F (2021) Cerebrovascular Complications Associated with Marijuana Use, Current Neurology and Neuroscience Reports, 10.1007/s11910-021-01113-2, 21:6, Online publication date: 1-Jun-2021.

Cadarette S, Maclure M, Delaney J, Whitaker H, Hayes K, Wang S, Tadrous M, Gagne J, Consiglio G and Hallas J (2021) Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology , Pharmacoepidemiology and Drug Safety, 10.1002/pds.5227, 30:6, (671-684), Online publication date: 1-Jun-2021.

Lim W, Suhail M and Galligan S A Case of Three-Vessel Coronary Artery Disease Associated With Marijuana Use, Cureus, 10.7759/cureus.14481

Alshaarawy O and Vanderziel A (2020) Visit-to-visit variability in blood pressure among cannabis users participating in the Third National Health and Nutrition Examination Survey, Journal of Hypertension, 10.1097/HJH.0000000000002702, 39:4, (621-626), Online publication date: 1-Apr-2021.

McGuinness B, Goel A, Elias F, Rapanos T, Mittleman M and Ladha K (2021) Cannabis use disorder and perioperative outcomes in vascular surgery, Journal of Vascular Surgery, 10.1016/j.jvs.2020.07.094, 73:4, (1376-1387.e3), Online publication date: 1-Apr-2021.

O’Keefe E, Peterson T and Lavie C (2021) Reevaluating America’s Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis, Current Opinion in Psychology, 10.1016/j.copsyc.2020.07.002, 38, (31-37), Online publication date: 1-Apr-2021.

Copeland-Halperin L, Herrera-Gomez L, LaPier J, Shank N and Shin J (2021)(2021) The Effects of Cannabis: Implications for the Surgical Patient, Plastic and Reconstructive Surgery - Global Open, 10.1097/GOX.0000000000003448, 9:3, (e3448)

Jakob J, Stalder O, Syrogiannouli L, Pletcher M, Vittinghoff E, Ning H, Tal K, Rana J, Sidney S, Lloyd‐Jones D and Auer R (2020) Association between marijuana use and electrocardiographic abnormalities by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study, Addiction, 10.1111/add.15188, 116:3, (583-595), Online publication date: 1-Mar-2021.

Di Fusco S, Rossini R, Flori M, Pollarolo L, Ingianni N, Malvezzi Caracciolo D’Aquino M, Galati G, Zilio F, Iorio A, Scotto di Uccio F, Lucà F, Gulizia M, Ciccirillo F, Gabrielli D and Colivicchi F (2020) Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000001091, 22:2, (79-89), Online publication date: 1-Feb-2021.

Pasha A, Clements C, Reynolds C, Lopez M, Lugo C, Gonzalez Y, Shirazi F and Abidov A (2021) Cardiovascular Effects of Medical Marijuana: A Systematic Review, The American Journal of Medicine, 10.1016/j.amjmed.2020.09.015, 134:2, (182-193), Online publication date: 1-Feb-2021.

Ibn Hadj Amor H, Touil I, Boukriba S, Bouchnak S, Kraiem S and Rouabhia R (2021) Case Report: Spontaneous simultaneous coronary and carotid dissection in a young cannabis user, F1000Research, 10.12688/f1000research.52606.2, 10, (387)

Ibn Hadj Amor H, Touil I, Boukriba S, Bouchnak S, Kraiem S and Rouabhia R (2021) Case Report: Spontaneous simultaneous coronary and carotid dissection in a young cannabis user, F1000Research, 10.12688/f1000research.52606.1, 10, (387)

Shukla P, Sharma R, Meshram R, Das A and Bastia B (2021) A cross-sectional study to assess the cardiovascular risk of chronic cannabis smoking through electrocardiograph (ECG), Emerging Trends in Drugs, Addictions, and Health, 10.1016/j.etdah.2021.100026, 1, (100026), .

Chetty K, Lavoie A and Dehghani P (2021) A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of, CJC Open, 10.1016/j.cjco.2020.09.001, 3:1, (12-21), Online publication date: 1-Jan-2021.

Kundra A (2021) Perioperative Management of Patients on Cannabis/Cannabinoids Cannabinoids and Pain, 10.1007/978-3-030-69186-8_29, (237-240), .

Liberale L, Montecucco F and Carbone F (2021) Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health, 10.1007/978-3-030-64872-5_17, (249-255), .

Dillane D and Snelgrove R (2021) Crohn’s Disease Preoperative Assessment, 10.1007/978-3-030-58842-7_24, (151-159), .

McGeeney B and Rzasa Lynn R (2021) Considerations for the Intersection of Sedation and Marijuana Pediatric Sedation Outside of the Operating Room, 10.1007/978-3-030-58406-1_44, (827-834), .

Jivanji D, Mangosing M, Mahoney S, Castro G, Zevallos J and Lozano J Association Between Marijuana Use and Cardiovascular Disease in US Adults, Cureus, 10.7759/cureus.11868

Gottschling S, Ayonrinde O, Bhaskar A, Blockman M, D’Agnone O, Schecter D, Suárez Rodríguez L, Yafai S and Cyr C (2020) <p>Safety Considerations in Cannabinoid-Based Medicine</p>, International Journal of General Medicine, 10.2147/IJGM.S275049, Volume 13, (1317-1333)

Montgomery S, Sirju K, Bear J, Ganti L and Shivdat J (2020) Recurrent priapism in the setting of cannabis use, Journal of Cannabis Research, 10.1186/s42238-020-0015-8, 2:1, Online publication date: 1-Dec-2020.

Auger N, Paradis G, Low N, Ayoub A, He S and Potter B (2020) Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study, BMC Medicine, 10.1186/s12916-020-01804-6, 18:1, Online publication date: 1-Dec-2020.

Davidson E, Raz N and Eyal A (2020) Anesthetic considerations in medical cannabis patients, Current Opinion in Anaesthesiology, 10.1097/ACO.0000000000000932, 33:6, (832-840), Online publication date: 1-Dec-2020.

Yahud E, Paul G, Rahkovich M, Vasilenko L, Kogan Y, Lev E, Laish-Farkash A, Mehta V, Robert S, Satish R, David N and Mark Philip C (2020) Cannabis induced cardiac arrhythmias: a case series, European Heart Journal - Case Reports, 10.1093/ehjcr/ytaa376, 4:6, (1-9), Online publication date: 1-Dec-2020.

Adamson M, Di Giovanni B and Delgado D (2020) The positive and negative cardiovascular effects of cannabis, Expert Review of Cardiovascular Therapy, 10.1080/14779072.2020.1837625, 18:12, (905-917), Online publication date: 1-Dec-2020.

Sun Y, Liu B, Wallace R and Bao W (2020) Association of Cannabis Use With All-Cause and Cause-Specific Mortality Among Younger- and Middle-Aged U.S. Adults, American Journal of Preventive Medicine, 10.1016/j.amepre.2020.07.010, 59:6, (873-879), Online publication date: 1-Dec-2020.

Narouze S, Strand N and Roychoudhury P (2020) Cannabinoids-based Medicine Pharmacology, Drug Interactions, and Perioperative Management of Surgical Patients, Advances in Anesthesia, 10.1016/j.aan.2020.08.004, 38, (167-188), Online publication date: 1-Dec-2020.

Mongiatti M, Bayle P, Lagarrigue A, Fabre D, Telmon N, Lapeyre-Mestre M and Jouanjus E (2020) The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisoners, Therapies, 10.1016/j.therap.2020.06.017, 75:6, (579-589), Online publication date: 1-Nov-2020.

Banerjee A, Gandhi A, Antony I, Alexander J, Hisbulla M, Kannichamy V, Kaleem I, Mishra V and Khan S Role of Cannabis in the Incidence of Myocardial Infarction: A Review, Cureus, 10.7759/cureus.11097

Lapeyre-Mestre M and Jouanjus E (2020) Cannabis et pathologies cardio-vasculaires, La Presse Médicale Formation, 10.1016/j.lpmfor.2020.08.009, 1:4, (355-363), Online publication date: 1-Oct-2020.

Orvos P, Pászti B, Topal L, Gazdag P, Prorok J, Polyák A, Kiss T, Tóth-Molnár E, Csupor-Löffler B, Bajtel Á, Varró A, Hohmann J, Virág L and Csupor D (2020) The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations, Scientific Reports, 10.1038/s41598-020-73165-2, 10:1

Page R, Allen L, Kloner R, Carriker C, Martel C, Morris A, Piano M, Rana J and Saucedo J (2020) Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association, Circulation, 142:10, (e131-e152), Online publication date: 8-Sep-2020.

Mahtta D, Khalid U, Misra A, Samad Z, Nasir K and Virani S (2020) Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?, Current Atherosclerosis Reports, 10.1007/s11883-020-00862-8, 22:9, Online publication date: 1-Sep-2020.

Schreier M, Williams C and Ma T Cardiac Ischemia Associated With Marijuana Use in an Adolescent, Cureus, 10.7759/cureus.9661

Emanuel T, Varney S, McRoy G and Tanaka K (2020) Cannabis and acute myocardial infarction, JAAPA, 10.1097/01.JAA.0000668804.51594.03, 33:8, (23-26), Online publication date: 1-Aug-2020.

O’Connor C, Anoushiravani A, Adams C, Young J, Richardson K and Rosenbaum A (2020) Cannabinoid Use in Musculoskeletal Illness: a Review of the Current Evidence, Current Reviews in Musculoskeletal Medicine, 10.1007/s12178-020-09635-x, 13:4, (379-384), Online publication date: 1-Aug-2020.

Winhusen T, Theobald J, Kaelber D and Lewis D (2019) The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2019.1676433, 46:4, (454-461), Online publication date: 3-Jul-2020.

Stupinski J, Bible L, Asmar S, Chehab M, Douglas M, Ditillo M, Gries L, Khurrum M and Joseph B (2020) Impact of marijuana on venous thromboembolic events: Cannabinoids cause clots in trauma patients, Journal of Trauma and Acute Care Surgery, 10.1097/TA.0000000000002667, 89:1, (125-131), Online publication date: 1-Jul-2020.

Franklin B, Brubaker P, Harber M, Lavie C, Myers J and Kaminsky L (2020) The Journal of Cardiopulmonary Rehabilitation and Prevention at 40 yr and Its Role in Promoting Preventive Cardiology: Part 2, Journal of Cardiopulmonary Rehabilitation and Prevention, 10.1097/HCR.0000000000000523, 40:4, (209-214), Online publication date: 1-Jul-2020.

Kloner R (2020) Editorial commentary: Continuing concerns about the cardiovascular safety of marijuana, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2019.08.008, 30:5, (308-309), Online publication date: 1-Jul-2020.

Patel R, Kamil S, Bachu R, Adikey A, Ravat V, Kaur M, Tankersley W and Goyal H (2020) Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2019.08.003, 30:5, (298-307), Online publication date: 1-Jul-2020.

Latif Z and Garg N (2020) The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use, Journal of Clinical Medicine, 10.3390/jcm9061925, 9:6, (1925)

Lynn R and Galinkin J (2020) Cannabis, e-cigarettes and anesthesia, Current Opinion in Anaesthesiology, 10.1097/ACO.0000000000000872, 33:3, (318-326), Online publication date: 1-Jun-2020.

Mura P, Underner M and Brunet B (2020) Le cannabis : similitudes et différences avec le tabac, Revue des Maladies Respiratoires, 10.1016/j.rmr.2020.04.002, 37:6, (479-487), Online publication date: 1-Jun-2020.

Brosnan T, Kolubinski D and Spada M (2020) Parenting styles and metacognitions as predictors of cannabis use, Addictive Behaviors Reports, 10.1016/j.abrep.2020.100259, 11, (100259), Online publication date: 1-Jun-2020.

Hall W and Lynskey M (2020) Assessing the public health impacts of legalizing recreational cannabis use: the US experience, World Psychiatry, 10.1002/wps.20735, 19:2, (179-186), Online publication date: 1-Jun-2020.

Bidaisee S (2020) Acute Coronary Syndrome And Cannabis: Consideration When Decriminalizing And Legalizing, Caribbean Medical Journal, 10.48107/CMJ.2020.05.001

Kwok C, Alraies M, Mohamed M, Rashid M, Shoaib A, Nolan J, Ratib K, Khoo C, Kontopantelis E and Mamas M (2020) Rates, predictors and the impact of cannabis misuse on in‐hospital outcomes among patients undergoing percutaneous coronary intervention (from the National Inpatient Sample), International Journal of Clinical Practice, 10.1111/ijcp.13477, 74:5, Online publication date: 1-May-2020.

Akasaki Y and Ohishi M (2019) Cerebrovascular and cardiovascular diseases caused by drugs of abuse, Hypertension Research, 10.1038/s41440-019-0367-7, 43:5, (363-371), Online publication date: 1-May-2020.

Revol B, Chittaro C, Frey P, Ferrando S, Guérin F, Pineau-Blondel E and Mallaret M (2020) Syndrome coronarien aigu associé au dronabinol, Therapies, 10.1016/j.therap.2019.07.001, 75:3, (309-311), Online publication date: 1-May-2020.

Hill M, Wong T, Davis M and Meier M (2020) Associations between cannabis use and retinal vessel diameter in young adults, Schizophrenia Research, 10.1016/j.schres.2019.02.016, 219, (62-68), Online publication date: 1-May-2020.

Farra Y, Eden M, Coleman J, Kulkarni P, Ferris C, Oakes J and Bellini C (2020) Acute neuroradiological, behavioral, and physiological effects of nose-only exposure to vaporized cannabis in C57BL/6 mice, Inhalation Toxicology, 10.1080/08958378.2020.1767237, 32:5, (200-217), Online publication date: 15-Apr-2020.

Goel A, McGuinness B, Jivraj N, Wijeysundera D, Mittleman M, Bateman B, Clarke H, Kotra L and Ladha K (2020) Cannabis Use Disorder and Perioperative Outcomes in Major Elective Surgeries, Anesthesiology, 10.1097/ALN.0000000000003067, 132:4, (625-635), Online publication date: 1-Apr-2020.

Olcina Rodriguez J, López Briz E and Olcina Domínguez P (2020) Seguridad cardiovascular del uso recreativo de cannabis asociado a sildenafilo: revisión sistemática, Revista Internacional de Andrología, 10.1016/j.androl.2018.12.003, 18:2, (75-78), Online publication date: 1-Apr-2020.

Rein J (2020) The nephrologistʼs guide to cannabis and cannabinoids, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000590, 29:2, (248-257), Online publication date: 1-Mar-2020.

Amatangelo M (2020) Cryptogenic Stroke, Critical Care Nursing Clinics of North America, 10.1016/j.cnc.2019.11.008, 32:1, (37-50), Online publication date: 1-Mar-2020.

Contreras A, Hall K, Vigil D, Rosenthal A, Azofeifa A and Van Dyke M (2019) Results from the Colorado Cannabis Users Survey on Health (CUSH), 2016, International Journal of Mental Health and Addiction, 10.1007/s11469-018-0047-x, 18:1, (1-13), Online publication date: 1-Feb-2020.

Burt J, Agha A, Yacoub B, Zahergivar A, Pepe J and den Uil C (2020) Marijuana use and coronary artery disease in young adults, PLOS ONE, 10.1371/journal.pone.0228326, 15:1, (e0228326)

Uguz B, Tiryakioglu K, Dal E, Tihan K, Yalin K and Ozkan H (2020) Acute effects of synthetic cannabinoids on ventricular repolarization, Sanamed, 10.24125/sanamed.v15i3.453, 15:3, (249-254), .

Hendrickson R, McKeown N, Kusin S and Lopez A (2020) Acute cannabis toxicity in older adults, Toxicology Communications, 10.1080/24734306.2020.1852821, 4:1, (67-70), Online publication date: 1-Jan-2020.

Chen-Sankey J, Jewett B, Orozco L, Duarte D, Dang K, Seaman E and Choi K (2019) “Hey, I Got to Smoke Some Weed”: Favorable Perceptions of Marijuana Use Among Non-College-Educated Young Adult Cigarette Smokers, Substance Use & Misuse, 10.1080/10826084.2019.1654515, 55:1, (48-55), Online publication date: 1-Jan-2020.

Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L and Singh M (2020) Acute Myocardial Infarction in Young Individuals, Mayo Clinic Proceedings, 10.1016/j.mayocp.2019.05.001, 95:1, (136-156), Online publication date: 1-Jan-2020.

Patel R, Manocha P, Patel J, Patel R and Tankersley W (2020) Cannabis Use Is an Independent Predictor for Acute Myocardial Infarction Related Hospitalization in Younger Population, Journal of Adolescent Health, 10.1016/j.jadohealth.2019.07.024, 66:1, (79-85), Online publication date: 1-Jan-2020.

DeFilippis E, Bajaj N, Singh A, Malloy R, Givertz M, Blankstein R, Bhatt D and Vaduganathan M (2020) Marijuana Use in Patients With Cardiovascular Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2019.11.025, 75:3, (320-332), Online publication date: 1-Jan-2020.

Schmid Y, Scholz I, Mueller L, Exadaktylos A, Ceschi A, Liechti M and Liakoni E (2020) Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2019.107726, 206, (107726), Online publication date: 1-Jan-2020.

Ishida J, Zhang A, Steigerwald S, Cohen B, Vali M and Keyhani S (2019) Sources of Information and Beliefs About the Health Effects of Marijuana, Journal of General Internal Medicine, 10.1007/s11606-019-05335-6, 35:1, (153-159), Online publication date: 1-Jan-2020.

Locatelli C, Lonati D and Petrolini V (2020) New Drugs of Abuse and Cardiovascular Function Brain and Heart Dynamics, 10.1007/978-3-319-90305-7_55-1, (1-27), .

Philip C, Seifried R, Bittencourt M and Hulten E (2020) Clinical Cardiovascular Effects of Cannabis Use Cannabis in Medicine, 10.1007/978-3-030-45968-0_9, (209-229), .

Randall K, Roberts B and Cienki J (2020) Acute Emergency Department Presentations Related to Cannabis Cannabis in Medicine, 10.1007/978-3-030-45968-0_6, (157-170), .

Hor M, Dzwonkowski M, Kolodziejczyk T, Muir L, Dubchak N, Hochroth S, Patel B, Wu A, Knight S, Smith G, Patel U, Remley Q and Hummer C (2020) Cannabinoids in Gastrointestinal Disorders Cannabis in Medicine, 10.1007/978-3-030-45968-0_17, (415-451), .

Antley C, Anderson R and Margulies J (2020) Cannabis in Dermatology Cannabis in Medicine, 10.1007/978-3-030-45968-0_15, (383-400), .

Kilmer J, Pasquariello C and Ferrera A (2020) Alcohol and Substance Abuse and Sport Mental Health in the Athlete, 10.1007/978-3-030-44754-0_9, (103-113), .

Locatelli C, Lonati D and Petrolini V (2020) New Drugs of Abuse and Cardiovascular Function Brain and Heart Dynamics, 10.1007/978-3-030-28008-6_55, (843-868), .

Fennich H, El Haddaji S, Oukerraj L, Zarzur J and Cherti M (2019) Acute myocardial infarction among young adults under 40 years of age. Risk factors, clinical and angiographic characteristics, Cor et Vasa, 10.33678/cor.2019.052, 61:6, (578-583), Online publication date: 15-Dec-2019.

Ladha K, Manoo V, Virji A, Hanlon J, Mclaren-Blades A, Goel A, Wijeysundera D, Kotra L, Ibarra C, Englesakis M and Clarke H (2019) The Impact of Perioperative Cannabis Use: A Narrative Scoping Review, Cannabis and Cannabinoid Research, 10.1089/can.2019.0054, 4:4, (219-230), Online publication date: 1-Dec-2019.

Morgan E, D’Aquila R, Carnethon M and Mustanski B (2019) Cardiovascular disease risk factors are elevated among a cohort of young sexual and gender minorities in Chicago, Journal of Behavioral Medicine, 10.1007/s10865-019-00038-z, 42:6, (1073-1081), Online publication date: 1-Dec-2019.

Wotring A, Paprzycki P, Wagner-Green V, Wygonik Q, Blavos A, Kruger J, Castor T, Diehr A and Glassman T (2018) Primary versus secondary prevention messages: College students' perceptions of effectiveness by marijuana user status, Journal of American College Health, 10.1080/07448481.2018.1506790, 67:8, (743-752), Online publication date: 17-Nov-2019.

Flannery K, D’Souza G and Agarwal R (2019) Perioperative Management of the Pediatric Patient on Medicinal Marijuana: What Anesthesiologists Should Know, Anesthesia & Analgesia, 10.1213/ANE.0000000000003956, 129:5, (1339-1343), Online publication date: 1-Nov-2019.

Alhamad T, Koraishy F, Lam N, Katari S, Naik A, Schnitzler M, Xiao H, Axelrod D, Dharnidharka V, Randall H, Ouseph R, Segev D, Brennan D, Devraj R, Kasiske B and Lentine K (2019) Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes, Transplantation, 10.1097/TP.0000000000002599, 103:11, (2373-2382), Online publication date: 1-Nov-2019.

Anzillotti L, Marezza F, Calò L, Banchini A and Cecchi R (2019) A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?, Legal Medicine, 10.1016/j.legalmed.2019.101637, 41, (101637), Online publication date: 1-Nov-2019.

Singh S, Koh M, Fang J and Ko D (2019) The Risk of Cardiovascular Events on Cannabis’ Highest Day, Canadian Journal of Cardiology, 10.1016/j.cjca.2019.05.020, 35:11, (1589-1591), Online publication date: 1-Nov-2019.

Donnadieu‐Rigole H, Jaubert L, Ursic‐Bedoya J, Hanslik B, Mura T, Gamon L, Faure S, Navarro F, Perney P, Herrero A and Pageaux G (2019)(2019) Integration of an Addiction Team in a Liver Transplantation Center, Liver Transplantation, 10.1002/lt.25641, 25:11, (1611-1619), Online publication date: 1-Nov-2019.

Richards J, Bing M, Moulin A, Elder J, Rominski R, Summers P and Laurin E (2019) Cannabis use and acute coronary syndrome, Clinical Toxicology, 10.1080/15563650.2019.1601735, 57:10, (831-841), Online publication date: 3-Oct-2019.

Rezkalla S and Kloner R (2019) Cardiovascular effects of marijuana, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2018.11.004, 29:7, (403-407), Online publication date: 1-Oct-2019.

Abdallah S, Jensen D and Lewthwaite H (2019) Updates in opioid and nonopioid treatment for chronic breathlessness, Current Opinion in Supportive & Palliative Care, 10.1097/SPC.0000000000000449, 13:3, (167-173), Online publication date: 1-Sep-2019.

Hill G, Izquierdo D, Boettcher B and Pagel P (2019) Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2018.11.041, 33:9, (2508-2512), Online publication date: 1-Sep-2019.

Fabresse N, Becam J, Carrara L, Descoeur J, Di Mario M, Drevin G, Duval T, Hannas N, Lanot T, Marillier M, Palayer M, Senechal H and Salle S (2019) Cannabinoïdes et thérapeutique, Toxicologie Analytique et Clinique, 10.1016/j.toxac.2019.06.002, 31:3, (153-172), Online publication date: 1-Sep-2019.

Williams R and Williams D (2019) Cannabinoids-Human Physiology and Agronomic Principles for Production Industrial Hemp as a Modern Commodity Crop, 10.2134/industrialhemp.c5, (73-91)

Winhusen T, Theobald J, Kaelber D and Lewis D (2019) Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings, Addiction, 10.1111/add.14607, 114:8, (1462-1470), Online publication date: 1-Aug-2019.

Goddard M (2019) Drugs and sudden cardiac death, Diagnostic Histopathology, 10.1016/j.mpdhp.2019.05.004, 25:8, (324-329), Online publication date: 1-Aug-2019.

Chami T and Kim C (2019) Cannabis Abuse and Elevated Risk of Myocardial Infarction in the Young: A Population-Based Study, Mayo Clinic Proceedings, 10.1016/j.mayocp.2019.05.008, 94:8, (1647-1649), Online publication date: 1-Aug-2019.

Manolis T, Manolis A and Manolis A Cannabis Associated “High” Cardiovascular Morbidity and Mortality: Marijuana Smoke Like Tobacco Smoke? A Déjà Vu/Déjà Vécu Story?, Mini-Reviews in Medicinal Chemistry, 10.2174/1389557518666181114113947, 19:11, (870-879)

Alexander J and Joshi G (2019) A review of the anesthetic implications of marijuana use, Baylor University Medical Center Proceedings, 10.1080/08998280.2019.1603034, 32:3, (364-371), Online publication date: 3-Jul-2019.

Gupta S, Namana V, Ambesh P, Kapoor S, Abbasi A and Kamholz S (2019) Medical Marijuana: Facts and Questions, American Journal of Therapeutics, 10.1097/MJT.0000000000000716, 26:4, (e502-e510), Online publication date: 1-Jul-2019.

Kim J and Brown D (2019) Medical Marijuana and the Patient With Chronic Pain, Topics in Pain Management, 10.1097/01.TPM.0000574296.65760.57, 34:12, (1-8), Online publication date: 1-Jul-2019.

Moon A, Smith W, Mullen S, Ponce B, McGwin G, Shah A and Naranje S (2019) Marijuana use and Mortality following Orthopedic Surgical Procedures, Substance Abuse, 10.1080/08897077.2018.1449054, 40:3, (378-382), Online publication date: 1-Jul-2019.

Buhmann C, Mainka T, Ebersbach G and Gandor F (2019) Evidence for the use of cannabinoids in Parkinson’s disease, Journal of Neural Transmission, 10.1007/s00702-019-02018-8, 126:7, (913-924), Online publication date: 1-Jul-2019.

Roberts B (2019) Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects, Western Journal of Emergency Medicine, 10.5811/westjem.2019.4.39935, 20:4, (557-572)

Cogan P (2019) On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements, Expert Review of Clinical Pharmacology, 10.1080/17512433.2019.1612743, 12:6, (501-511), Online publication date: 3-Jun-2019.

Ghosh M and Naderi S (2019) Cannabis and Cardiovascular Disease, Current Atherosclerosis Reports, 10.1007/s11883-019-0783-9, 21:6, Online publication date: 1-Jun-2019.

Lepez C, Mehtelli W, Azuar J, Bellivier F and Vorspan F (2019) Caractéristiques des usagers de cannabis dans un cabinet de médecine générale en France, Revue d'Épidémiologie et de Santé Publique, 10.1016/j.respe.2019.02.002, 67:3, (175-180), Online publication date: 1-May-2019.

Drummer O, Gerostamoulos D and Woodford N (2019) Cannabis as a cause of death: A review, Forensic Science International, 10.1016/j.forsciint.2019.03.007, 298, (298-306), Online publication date: 1-May-2019.

Richards J, Singh G, Parikh A and Venugopal S (2019) Acute coronary syndrome after cannabis use: Correlation with quantitative toxicology testing, The American Journal of Emergency Medicine, 10.1016/j.ajem.2019.02.017, 37:5, (1007.e1-1007.e4), Online publication date: 1-May-2019.

Sánchez Artiles A, Awan A, Karl M and Santini A (2019) Cardiovascular effects of cannabis (marijuana): A timely update, Phytotherapy Research, 10.1002/ptr.6315, 33:5, (1592-1594), Online publication date: 1-May-2019.

Cohen K, Weizman A and Weinstein A (2019) Positive and Negative Effects of Cannabis and Cannabinoids on Health, Clinical Pharmacology & Therapeutics, 10.1002/cpt.1381, 105:5, (1139-1147), Online publication date: 1-May-2019.

Meier M, Pardini D, Beardslee J and Matthews K (2019) Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men, Psychosomatic Medicine, 10.1097/PSY.0000000000000665, 81:3, (281-288), Online publication date: 1-Apr-2019.

Spagnoli V, Diefenbronn M, Merat B, Logeart D, Sideris G, Henry P, Manzo-Silberman S, Drouet L and Dillinger J (2019) Syndrome coronarien aigu avec sus-décalage du segment ST chez les jeunes adultes : le bilan de thrombophilie a-t-il un intérêt ?, Annales de Cardiologie et d'Angéiologie, 10.1016/j.ancard.2018.09.012, 68:2, (98-106), Online publication date: 1-Apr-2019.

Briscoe J, Kamal A and Casarett D (2019) Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis, Journal of Palliative Medicine, 10.1089/jpm.2018.0641, 22:3, (319-325), Online publication date: 1-Mar-2019.

Banks K, Biswas S, Wong M, Byerly S, Clark D, Lam L, Inaba K and Demetriades D (2019) Cannabis Use is Associated with Increased Mechanical Ventilation and Polysubstance Use in Trauma Patients, The American Surgeon, 10.1177/000313481908500234, 85:2, (226-229), Online publication date: 1-Feb-2019.

Benowitz N (2019) Managing Cannabis Use in Patients With Cardiovascular Disease, Canadian Journal of Cardiology, 10.1016/j.cjca.2018.12.033, 35:2, (138-141), Online publication date: 1-Feb-2019.

Saunders A and Stevenson R (2019) Marijuana Lollipop-Induced Myocardial Infarction, Canadian Journal of Cardiology, 10.1016/j.cjca.2018.11.033, 35:2, (229.e1-229.e3), Online publication date: 1-Feb-2019.

Ho C, Martinusen D and Lo C (2019) A Review of Cannabis in Chronic Kidney Disease Symptom Management, Canadian Journal of Kidney Health and Disease, 10.1177/2054358119828391, 6, (205435811982839), Online publication date: 1-Jan-2019.

Toce M, Farias M, Powell A, Daly K, Vargas S and Burns M (2018) Myocardial Infarct After Marijuana Inhalation in a 16-year-old Adolescent Boy, Pediatric and Developmental Pathology, 10.1177/1093526618785552, 22:1, (80-86), Online publication date: 1-Jan-2019.

Hämmig R, Preuss U and Soyka M (2019) Cannabis Suchtmedizin, 10.1016/B978-3-437-23021-9.00009-6, (143-175), .

Owens D (2019) Lifestyle Modification: Diet, Exercise, Sports, and Other Issues Hypertrophic Cardiomyopathy, 10.1007/978-3-319-92423-6_12, (169-182), .

Khalsa J and Baler R (2019) Medical Consequences of Cannabis Use Cannabis Use Disorders, 10.1007/978-3-319-90365-1_15, (157-167), .

DePace N and Colombo J (2019) Mind-Body Wellness Program Benefits Clinical Autonomic and Mitochondrial Disorders, 10.1007/978-3-030-17016-5_9, (397-499), .

Bhatt N, Malik A and Chaturvedi S (2018) Stroke in young adults, Neurology Clinical Practice, 10.1212/CPJ.0000000000000522, 8:6, (501-506), Online publication date: 1-Dec-2018.

Kumar S, Srinivasamurthy R, Karasik O and Javaid A (2018) Marijuana-associated ST-elevation myocardial infarction: is this a benign drug, BMJ Case Reports, 10.1136/bcr-2018-226894, 11:1, (e226894), Online publication date: 1-Dec-2018.

Clark T, Jones J, Hall A, Tabner S and Kmiec R (2018) Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users , Cannabis and Cannabinoid Research, 10.1089/can.2018.0045, 3:1, (259-271), Online publication date: 1-Dec-2018.

Schwartz B, Kloner R and Naghavi M (2018) Acute and Subacute Triggers of Cardiovascular Events, The American Journal of Cardiology, 10.1016/j.amjcard.2018.08.049, 122:12, (2157-2165), Online publication date: 1-Dec-2018.

Mostofsky E, Coull B and Mittleman M (2018) Analysis of Observational Self-matched Data to Examine Acute Triggers of Outcome Events with Abrupt Onset, Epidemiology, 10.1097/EDE.0000000000000904, 29:6, (804-816), Online publication date: 1-Nov-2018.

Njei B, Sharma P, McCarty T, Singh M, Haque L, Aslanian H, Jamidar P and Muniraj T (2018) Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis, Pancreas, 10.1097/MPA.0000000000001143, 47:9, (1142-1149), Online publication date: 1-Oct-2018.

Kalla A, Krishnamoorthy P, Gopalakrishnan A and Figueredo V (2018) Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000000681, 19:9, (480-484), Online publication date: 1-Sep-2018.

Knapp-Gisclon A, Mayer-Duverneuil C, de la Grandmaison G, Cappy J and Alvarez J (2018) Décès d’origine cardiaque avec présence de THC dans le sang, quel lien possible ? Étude de 33 cas, Toxicologie Analytique et Clinique, 10.1016/j.toxac.2018.04.114, 30:3, (195-205), Online publication date: 1-Sep-2018.

Wei B, Smith D, O’Connor R, Travers M and Hyland A (2018) Examining the Association between Body Burdens of Harmful Chemicals and Heaviness of Marijuana Smoking, Chemical Research in Toxicology, 10.1021/acs.chemrestox.8b00160, 31:8, (643-645), Online publication date: 20-Aug-2018.

Katz-Talmor D, Katz I, Porat-Katz B and Shoenfeld Y (2018) Cannabinoids for the treatment of rheumatic diseases — where do we stand?, Nature Reviews Rheumatology, 10.1038/s41584-018-0025-5, 14:8, (488-498), Online publication date: 1-Aug-2018.

Rice J and Cameron M (2018) Cannabinoids for Treatment of MS Symptoms: State of the Evidence, Current Neurology and Neuroscience Reports, 10.1007/s11910-018-0859-x, 18:8, Online publication date: 1-Aug-2018.

Alfulaij N, Meiners F, Michalek J, Small‐Howard A, Turner H and Stokes A (2018) Cannabinoids, the Heart of the Matter, Journal of the American Heart Association, 7:14, Online publication date: 17-Jul-2018.

Johnson-Sasso C, Tompkins C, Kao D, Walker L and Aalto-Setala K (2018) Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction, PLOS ONE, 10.1371/journal.pone.0199705, 13:7, (e0199705)

Paul A, Simms L, Amini S and Paul A (2017) Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use, Journal of Forensic Sciences, 10.1111/1556-4029.13704, 63:4, (1321-1324), Online publication date: 1-Jul-2018.

Ouali S, Guermazi O, Guermazi F, Halima M, Boudiche S, Khedher N, Meghaieth F, Farhati A, Larbi N and Mourali M (2018) Drug Abuse-Induced Cardiac Arrhythmias: Mechanisms and Management Cardiac Arrhythmias, 10.5772/intechopen.76022

Singh A, Saluja S, Kumar A, Agrawal S, Thind M, Nanda S and Shirani J (2017) Cardiovascular Complications of Marijuana and Related Substances: A Review, Cardiology and Therapy, 10.1007/s40119-017-0102-x, 7:1, (45-59), Online publication date: 1-Jun-2018.

Briscoe J and Casarett D (2018) Medical Marijuana Use in Older Adults, Journal of the American Geriatrics Society, 10.1111/jgs.15346, 66:5, (859-863), Online publication date: 1-May-2018.

Auer R, Sidney S, Goff D, Vittinghoff E, Pletcher M, Allen N, Reis J, Lewis C, Carr J and Rana J (2018) Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study, Addiction, 10.1111/add.14110, 113:5, (845-856), Online publication date: 1-May-2018.

León O, Aguiar L, Quevedo L and Jara A (2018) Efectos cardiovasculares debido al consumo de cannabinoides, Revista Colombiana de Cardiología, 10.1016/j.rccar.2017.11.030, 25:3, (230-235), Online publication date: 1-May-2018.

Bancks M, Auer R, Carr J, Goff D, Kiefe C, Rana J, Reis J, Sidney S, Terry J and Schreiner P (2017) Self‐reported marijuana use over 25 years and abdominal adiposity: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, Addiction, 10.1111/add.14097, 113:4, (689-698), Online publication date: 1-Apr-2018.

Lu C, Papatheodorou S, Danziger J and Mittleman M (2018) Marijuana Use and Renal Function Among US Adults, The American Journal of Medicine, 10.1016/j.amjmed.2017.10.051, 131:4, (408-414), Online publication date: 1-Apr-2018.

Lovell M, Bruno R, Johnston J, Matthews A, McGregor I, Allsop D and Lintzeris N (2018) Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco users, Addictive Behaviors, 10.1016/j.addbeh.2017.12.009, 79, (178-188), Online publication date: 1-Apr-2018.

Pacher P, Steffens S, Haskó G, Schindler T and Kunos G (2017) Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly, Nature Reviews Cardiology, 10.1038/nrcardio.2017.130, 15:3, (151-166), Online publication date: 1-Mar-2018.

Abouk R and Adams S (2018) Examining the relationship between medical cannabis laws and cardiovascular deaths in the US, International Journal of Drug Policy, 10.1016/j.drugpo.2017.11.022, 53, (1-7), Online publication date: 1-Mar-2018.

Fairman B and Anthony J (2017) Does Starting to Smoke Cigars Trigger Onset of Cannabis Blunt Smoking?, Nicotine & Tobacco Research, 10.1093/ntr/ntx015, 20:3, (355-361), Online publication date: 7-Feb-2018.

Rein J and Wyatt C (2018) Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD, American Journal of Kidney Diseases, 10.1053/j.ajkd.2017.06.020, 71:2, (267-274), Online publication date: 1-Feb-2018.

Robinson J, Somasegar S, Shivapour J and Snyder C (2018) ECG Findings in Pediatric Patients under the Influence of Marijuana, Cannabis, 10.26828/cannabis.2018.01.004, 1:1, (28-34)

Šimůnek L, Krajina A, Herzig R and Vališ M (2018) Cerebral Infarction in Young Marijuana Smokers – Case Reports, Acta Medica (Hradec Kralove, Czech Republic), 10.14712/18059694.2018.56, 61:2, (74-77), .

Khadanga S and Ades P (2018) What do we tell patients with coronary artery disease about marijuana use?, Coronary Artery Disease, 10.1097/MCA.0000000000000567, 29:1, (1-3), Online publication date: 1-Jan-2018.

Orenstein D and Glantz S (2018) Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control, Journal of Psychoactive Drugs, 10.1080/02791072.2017.1422816, 50:1, (19-32), Online publication date: 1-Jan-2018.

Huss-Bawab J, Fishbein G and Fishbein M (2018) Role of the Cardiac Pathologist in Evaluating Sudden Natural Deaths Multidisciplinary Medico-Legal Death Investigation, 10.1016/B978-0-12-813818-2.00008-9, (139-191), .

Starobin B, Jablonski S, Andrle A and Powers J (2018) Recreational Drugs: Effects on the Heart and Cardiovascular System Encyclopedia of Cardiovascular Research and Medicine, 10.1016/B978-0-12-809657-4.99731-X, (240-248), .

Powers J (2018) OBSOLETE: Recreational Drugs: Effects on the Heart and Cardiovascular System Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99731-9, .

Vadivelu N, Kai A, Kodumudi G, Sramcik J and Kaye A (2018) Medical Marijuana: Current Concepts, Pharmacological Actions of Cannabinoid Receptor Mediated Activation, and Societal Implications, Current Pain and Headache Reports, 10.1007/s11916-018-0656-x, 22:1, Online publication date: 1-Jan-2018.

Kemmeter P and Krebill E (2018) Preoperative Preparation and Workup Global Bariatric Surgery, 10.1007/978-3-319-93545-4_34, (351-377), .

Harbaoui B (2017) Complications cardiovasculaires de la toxicomanie, Journal Européen des Urgences et de Réanimation, 10.1016/j.jeurea.2017.10.004, 29:4, (337-344), Online publication date: 1-Dec-2017.

Nicholls S and Miller C (2017) Taking the lid off the pot on marijuana and cardiovascular disease, European Journal of Preventive Cardiology, 10.1177/2047487317734045, 24:17, (1831-1832), Online publication date: 1-Nov-2017.

Yankey B, Rothenberg R, Strasser S, Ramsey-White K and Okosun I (2017) RETRACTED: Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file, European Journal of Preventive Cardiology, 10.1177/2047487317723212, 24:17, (1833-1840), Online publication date: 1-Nov-2017.

Wood D (2017) The cardiovascular effects of cannabis and cannabinoids: Myth or reality?, Toxicology Letters, 10.1016/j.toxlet.2017.07.182, 280, (S71), Online publication date: 1-Oct-2017.

Draz E, Oreby M, Elsheikh E, Khedr L and Atlam S (2016) Marijuana use in acute coronary syndromes, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2016.1240800, 43:5, (576-582), Online publication date: 3-Sep-2017.

Maclure M (2017) Using Simulated Data to Assess Case-Crossover Designs for Studying Less Transient Effects of Drugs, Drug Safety, 10.1007/s40264-017-0549-7, 40:9, (757-760), Online publication date: 1-Sep-2017.

Hoffman K, Ponce Terashima J, McCarty D and Muench J (2017) Toward a Patient Registry for Cannabis Use: An Exploratory Study of Patient Use in an Outpatient Health‐Care Clinic in Oregon, World Medical & Health Policy, 10.1002/wmh3.237, 9:3, (307-317), Online publication date: 1-Sep-2017.

Lorenz D, Dutta A, Mukerji S, Holman A, Uno H and Gabuzda D (2017) Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men, Clinical Infectious Diseases, 10.1093/cid/cix391, 65:4, (626-635), Online publication date: 15-Aug-2017.

Preuss U and Hoch E (2017) Psychische und somatische Störungen durch Cannabiskonsum, DNP - Der Neurologe & Psychiater, 10.1007/s15202-017-1499-8, 18:6, (45-54), Online publication date: 1-Jun-2017.

Feingold D, Rehm J and Lev-Ran S (2017) Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study, Psychiatry Research, 10.1016/j.psychres.2017.02.027, 251, (225-234), Online publication date: 1-May-2017.

Reis J, Auer R, Bancks M, Goff D, Lewis C, Pletcher M, Rana J, Shikany J and Sidney S (2017) Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, American Journal of Public Health, 10.2105/AJPH.2017.303654, 107:4, (601-606), Online publication date: 1-Apr-2017.

Pierard S and Hantson P (2017) Coronary vasospasm complicating cannabinoid hyperemesis syndrome, Journal of Cardiology Cases, 10.1016/j.jccase.2016.12.001, 15:4, (115-118), Online publication date: 1-Apr-2017.

Harbaoui B (2017) Complications cardiovasculaires de la toxicomanie, Archives des Maladies du Coeur et des Vaisseaux - Pratique, 10.1016/j.amcp.2017.01.010, 2017:256, (11-18), Online publication date: 1-Mar-2017.

Soyka M, Preuss U and Hoch E (2017) Cannabisinduzierte Störungen Cannabis-induced disorders, Der Nervenarzt, 10.1007/s00115-017-0281-7, 88:3, (311-325), Online publication date: 1-Mar-2017.

Smeijers L, Mostofsky E, Tofler G, Muller J, Kop W and Mittleman M (2017) Anxiety and anger immediately prior to myocardial infarction and long-term mortality: Characteristics of high-risk patients, Journal of Psychosomatic Research, 10.1016/j.jpsychores.2016.12.001, 93, (19-27), Online publication date: 1-Feb-2017.

Deborde T and Brisacier A (2017) Usage de cannabis et complications cardio-vasculaires et neuro-vasculaires, Psychotropes, 10.3917/psyt.223.0157, Vol. 22:3, (157-183), Online publication date: 23-Jan-2017.

Kim D and So W (2016) The Relationships Between Recreational Drug Abuse and School Records Among Korean Adolescents, Journal of Child & Adolescent Substance Abuse, 10.1080/1067828X.2015.1009604, 26:1, (86-90), Online publication date: 2-Jan-2017.

Ul Haq E, Shafiq A, Khan A, Awan A, Ezad S, Minteer W and Omar B (2017) “Spice” (Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series, Case Reports in Cardiology, 10.1155/2017/9252463, 2017, (1-4), .

Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E and Molina-Holgado F (2017) Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events Cannabinoid Pharmacology, 10.1016/bs.apha.2017.05.001, (135-168), .

Sweis R and Biller J (2017) Toxicity/Substance Abuse Primer on Cerebrovascular Diseases, 10.1016/B978-0-12-803058-5.00120-X, (614-622), .

Fernández A, Barbería E, Marrón T and Medallo J (2017) On-Site Drug Testing for Cannabis Handbook of Cannabis and Related Pathologies, 10.1016/B978-0-12-800756-3.00119-8, (998-1006), .

Barber P (2017) Cannabis and Stroke Handbook of Cannabis and Related Pathologies, 10.1016/B978-0-12-800756-3.00059-4, (486-493), .

Menahem S (2017) Cardiovascular Effects of Cannabis Usage Handbook of Cannabis and Related Pathologies, 10.1016/B978-0-12-800756-3.00058-2, (481-485), .

Vin‐Raviv N, Akinyemiju T, Meng Q, Sakhuja S and Hayward R (2016) Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database, Cancer Medicine, 10.1002/cam4.968, 6:1, (320-329), Online publication date: 1-Jan-2017.

Zupan Mežnar A, Brvar M, Kralj G and Kovačič D (2016) Accidental cannabis poisoning in the elderly, Wiener klinische Wochenschrift, 10.1007/s00508-016-1136-0, 128:S7, (548-552), Online publication date: 1-Dec-2016.

Dewald O (2016) Effekte des Endocannabinoidrezeptors CB2 auf die myokardiale Protektion Effects of endocannabinoid receptor CB2 on myocardial protection, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 10.1007/s00398-016-0087-0, 30:6, (415-419), Online publication date: 1-Dec-2016.

LENOUE S, WONGNGAMNIT N and THURSTONE C (2016) Practical Aspects of Discussing Marijuana in a New Era, Journal of Psychiatric Practice, 10.1097/PRA.0000000000000189, 22:6, (471-477), Online publication date: 1-Nov-2016.

Richardson K, Hester A and McLemore G (2016) Prenatal cannabis exposure - The “first hit” to the endocannabinoid system, Neurotoxicology and Teratology, 10.1016/j.ntt.2016.08.003, 58, (5-14), Online publication date: 1-Nov-2016.

Sidney S (2016) Marijuana Use and Type 2 Diabetes Mellitus: a Review, Current Diabetes Reports, 10.1007/s11892-016-0795-6, 16:11, Online publication date: 1-Nov-2016.

(2016) Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species Cannabis, 10.1201/9781315367583-20, (229-252)

Scholl A, Ivanov I and Hinz B (2016) Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2, Oncotarget, 10.18632/oncotarget.11367, 7:38, (61438-61457), Online publication date: 20-Sep-2016.

Rezkalla S, Stankowski R and Kloner R (2016) Cardiovascular Effects of Marijuana, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248415627874, 21:5, (452-455), Online publication date: 1-Sep-2016.

Wilsey B, Marcotte T, Deutsch R, Zhao H, Prasad H and Phan A (2016) An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease, The Journal of Pain, 10.1016/j.jpain.2016.05.010, 17:9, (982-1000), Online publication date: 1-Sep-2016.

Wilson K (2016) Secondhand Marijuana Smoke Is Not Benign, Journal of the American Heart Association, 5:8, Online publication date: 8-Aug-2016.

Wang X, Derakhshandeh R, Liu J, Narayan S, Nabavizadeh P, Le S, Danforth O, Pinnamaneni K, Rodriguez H, Luu E, Sievers R, Schick S, Glantz S and Springer M (2016) One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function, Journal of the American Heart Association, 5:8, Online publication date: 8-Aug-2016.

Alshaarawy O and Elbaz H (2016) Cannabis use and blood pressure levels, Journal of Hypertension, 10.1097/HJH.0000000000000990, 34:8, (1507-1512), Online publication date: 1-Aug-2016.

Haardörfer R, Berg C, Lewis M, Payne J, Pillai D, McDonald B and Windle M (2016) Polytobacco, marijuana, and alcohol use patterns in college students: A latent class analysis, Addictive Behaviors, 10.1016/j.addbeh.2016.03.034, 59, (58-64), Online publication date: 1-Aug-2016.

Neyer J, Uberoi A, Hamilton M and Kobashigawa J (2016) Marijuana and Listing for Heart Transplant, Circulation: Heart Failure, 9:7, Online publication date: 1-Jul-2016.

Franz C and Frishman W (2016) Marijuana Use and Cardiovascular Disease, Cardiology in Review, 10.1097/CRD.0000000000000103, 24:4, (158-162), Online publication date: 1-Jul-2016.

Shah M, Garg J, Patel B, Guthier J and Freudenberger R (2016) Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus, International Journal of Cardiology, 10.1016/j.ijcard.2016.04.055, 215, (129-131), Online publication date: 1-Jul-2016.

Bouccin E, Eloye H and Hantson P (2016) Complications vasculaires périphériques, cardiaques et cérébrales associées à l’utilisation du cannabis, Toxicologie Analytique et Clinique, 10.1016/j.toxac.2016.01.002, 28:2, (115-128), Online publication date: 1-Jun-2016.

Papatheodorou S, Buettner H, Rice M and Mittleman M (2016) Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States, Chest, 10.1016/j.chest.2015.12.033, 149:6, (1428-1435), Online publication date: 1-Jun-2016.

Grafton S, Huang P and Vieira A (2016) Dental treatment planning considerations for patients using cannabis, The Journal of the American Dental Association, 10.1016/j.adaj.2015.11.019, 147:5, (354-361), Online publication date: 1-May-2016.

Hauben M, Aronson J and Ferner R (2016) Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP), Drug Safety, 10.1007/s40264-016-0392-2, 39:5, (421-432), Online publication date: 1-May-2016.

Schrot R and Hubbard J (2016) Cannabinoids: Medical implications, Annals of Medicine, 10.3109/07853890.2016.1145794, 48:3, (128-141), Online publication date: 2-Apr-2016.

Fuster D, Cheng D, Wang N, Bernstein J, Palfai T, Alford D, Samet J and Saitz R (2016) Brief Intervention for Daily Marijuana Users Identified by Screening in Primary Care: A Subgroup Analysis of the ASPIRE Randomized Clinical Trial, Substance Abuse, 10.1080/08897077.2015.1075932, 37:2, (336-342), Online publication date: 1-Apr-2016.

Eichner E (2016) Never Take Your Heart by Surprise, Current Sports Medicine Reports, 10.1249/JSR.0000000000000234, 15:2, (65-66), Online publication date: 1-Mar-2016.

Hashmi H, Duncalf R and Khaja M (2016) A Case Report of Cannabis Induced Hemoptysis, Medicine, 10.1097/MD.0000000000003232, 95:13, (e3232), Online publication date: 1-Mar-2016.

Wei B, Alwis K, Li Z, Wang L, Valentin-Blasini L, Sosnoff C, Xia Y, Conway K and Blount B (2016) Urinary concentrations of PAH and VOC metabolites in marijuana users, Environment International, 10.1016/j.envint.2015.12.003, 88, (1-8), Online publication date: 1-Mar-2016.

Rumalla K, Reddy A and Mittal M (2016) Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2015.10.019, 25:2, (452-460), Online publication date: 1-Feb-2016.

Arria A, Caldeira K, Bugbee B, Vincent K and O’Grady K (2016) Marijuana use trajectories during college predict health outcomes nine years post-matriculation, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2015.12.009, 159, (158-165), Online publication date: 1-Feb-2016.

Vidot D, Prado G, Hlaing W, Florez H, Arheart K and Messiah S (2016) Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data, The American Journal of Medicine, 10.1016/j.amjmed.2015.10.019, 129:2, (173-179), Online publication date: 1-Feb-2016.

Kelly S, Plankey M, Post W, Li X, Stall R, Jacobson L, Witt M, Kingsley L, Cox C, Budoff M, Palella F and Apetrei C (2016) Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study, PLOS ONE, 10.1371/journal.pone.0147822, 11:1, (e0147822)

Tait R, Caldicott D, Mountain D, Hill S and Lenton S (2015) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment, Clinical Toxicology, 10.3109/15563650.2015.1110590, 54:1, (1-13), Online publication date: 2-Jan-2016.

Elsheshtawy M, Sriganesh P, Virparia V, Patel F and Khanna A (2016) Synthetic Marijuana Induced Acute Nonischemic Left Ventricular Dysfunction, Case Reports in Cardiology, 10.1155/2016/9625758, 2016, (1-4), .

Danielsson A, Lundin A, Yaregal A, Östenson C, Allebeck P and Agardh E (2016) Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women, Journal of Diabetes Research, 10.1155/2016/6278709, 2016, (1-6), .

(2016) Cannabinoids Meyler's Side Effects of Drugs, 10.1016/B978-0-444-53717-1.00444-3, (48-70), .

Brust J (2016) Stroke and Substance Abuse Stroke, 10.1016/B978-0-323-29544-4.00039-6, (648-657.e14), .

Fishbein M (2016) Toxins and the Heart Cardiovascular Pathology, 10.1016/B978-0-12-420219-1.00017-3, (721-733), .

Desbois A and Cacoub P (2016) Cannabis-Associated Vasculitis Systemic Vasculitides: Current Status and Perspectives, 10.1007/978-3-319-40136-2_32, (377-383), .

Marchetti D, Spagnolo A, De Matteis V, Filograna L and De Giovanni N (2015) Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature, Drug Testing and Analysis, 10.1002/dta.1898, 8:1, (56-62), Online publication date: 1-Jan-2016.

Wilsey B, Atkinson J, Marcotte T and Grant I (2015) The Medicinal Cannabis Treatment Agreement, The Clinical Journal of Pain, 10.1097/AJP.0000000000000145, 31:12, (1087-1096), Online publication date: 1-Dec-2015.

Dines A, Wood D, Galicia M, Yates C, Heyerdahl F, Hovda K, Giraudon I, Sedefov R and Dargan P (2015) Presentations to the Emergency Department Following Cannabis use—a Multi-Centre Case Series from Ten European Countries, Journal of Medical Toxicology, 10.1007/s13181-014-0460-x, 11:4, (415-421), Online publication date: 1-Dec-2015.

Hirapara K and Aggarwal R (2015) Synthetic Cannabis and Myocardial Infarction: A Complication Less Known!, Psychosomatics, 10.1016/j.psym.2015.07.009, 56:6, (712-713), Online publication date: 1-Nov-2015.

Capilla E, Poyet R, Brocq F, Pons F, Kerebel S, Jego C, Laurent P and Cellarier G (2015) Complications cardiaques des médicaments, La Presse Médicale, 10.1016/j.lpm.2015.04.037, 44:10, (995-1002), Online publication date: 1-Oct-2015.

Karabowicz P, Schlicker E, Pędzińska-Betiuk A, Kloza M and Malinowska B (2015) The adrenal medulla, not CB1 receptors, mediates the inhibitory effect of acute transverse aortic constriction on the neurogenic vasopressor response, Life Sciences, 10.1016/j.lfs.2014.11.032, 138, (86-93), Online publication date: 1-Oct-2015.

Kaar S, Gao C, Lloyd B, Smith K and Lubman D (2015) Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2015.08.021, 155, (24-30), Online publication date: 1-Oct-2015.

Clark B, Georgekutty J and Berul C (2015) Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients, The Journal of Pediatrics, 10.1016/j.jpeds.2015.06.001, 167:3, (757-761.e1), Online publication date: 1-Sep-2015.

Velibey Y, Sahin S, Tanık O, Keskin M, Bolca O and Eren M (2015) Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated, The American Journal of Emergency Medicine, 10.1016/j.ajem.2015.01.032, 33:8, (1114.e1-1114.e3), Online publication date: 1-Aug-2015.

Baron E (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …, Headache: The Journal of Head and Face Pain, 10.1111/head.12570, 55:6, (885-916), Online publication date: 1-Jun-2015.

(2015) XXXV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 26–29 May 2015, St Julian's, Malta, Clinical Toxicology, 10.3109/15563650.2015.1024953, 53:4, (233-403), Online publication date: 21-Apr-2015.

Hoch E, Bonnet U, Thomasius R, Ganzer F, Havemann-Reinecke U and Preuss U (2015) Risks Associated With the Non-Medicinal Use of Cannabis, Deutsches Ärzteblatt international, 10.3238/arztebl.2015.0271

Okaneku J, Vearrier D, McKeever R, LaSala G and Greenberg M (2015) Change in perceived risk associated with marijuana use in the United States from 2002 to 2012, Clinical Toxicology, 10.3109/15563650.2015.1004581, 53:3, (151-155), Online publication date: 16-Mar-2015.

McKeever R, Vearrier D, Jacobs D, LaSala G, Okaneku J and Greenberg M (2014) K2—Not the Spice of Life; Synthetic Cannabinoids and ST Elevation Myocardial Infarction: A Case Report, Journal of Medical Toxicology, 10.1007/s13181-014-0424-1, 11:1, (129-131), Online publication date: 1-Mar-2015.

Zhang L, Morgenstern H, Greenland S, Chang S, Lazarus P, Teare M, Woll P, Orlow I, Cox B, Brhane Y, Liu G and Hung R (2014) Cannabis smoking and lung cancer risk: Pooled analysis in the I nternational L ung C ancer C onsortium , International Journal of Cancer, 10.1002/ijc.29036, 136:4, (894-903), Online publication date: 15-Feb-2015.

Berg C, Stratton E, Schauer G, Lewis M, Wang Y, Windle M and Kegler M (2014) Perceived Harm, Addictiveness, and Social Acceptability of Tobacco Products and Marijuana Among Young Adults: Marijuana, Hookah, and Electronic Cigarettes Win, Substance Use & Misuse, 10.3109/10826084.2014.958857, 50:1, (79-89), Online publication date: 2-Jan-2015.

Orsini J, Blaak C, Tam E, Rajayer S, Morante J, Yeh A and Butala A (2015) The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity, Case Reports in Critical Care, 10.1155/2015/542490, 2015, (1-5), .

Hall W (2014) What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?, Addiction, 10.1111/add.12703, 110:1, (19-35), Online publication date: 1-Jan-2015.

Kollins S, Schoenfelder E, English J, Holdaway A, Van Voorhees E, O’Brien B, Dew R and Chrisman A (2015) An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults, Journal of Substance Abuse Treatment, 10.1016/j.jsat.2014.07.014, 48:1, (96-103), Online publication date: 1-Jan-2015.

Francis R and Ghuran A (2015) Cardiovascular Toxicity as a Result of Recreational Drugs Heart and Toxins, 10.1016/B978-0-12-416595-3.00015-3, (459-491), .

Moore P, Kao D and Krantz M (2015) Cardiovascular Consequences of Addiction Textbook of Addiction Treatment: International Perspectives, 10.1007/978-88-470-5322-9_78, (1577-1609), .

Owens D (2015) Lifestyle Modification: Diet, Exercise, Sports and Other Issues Hypertrophic Cardiomyopathy, 10.1007/978-1-4471-4956-9_12, (143-154), .

Hodcroft C, Rossiter M and Buch A (2014) Cannabis-associated Myocardial Infarction in a Young Man with Normal Coronary Arteries, The Journal of Emergency Medicine, 10.1016/j.jemermed.2013.11.077, 47:3, (277-281), Online publication date: 1-Sep-2014.

Khullar V, Jain A and Sattari M (2014) Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones, Journal of General Internal Medicine, 10.1007/s11606-014-2802-4, 29:8, (1200-1204), Online publication date: 1-Aug-2014.

Anselmino M, Matta M and Gaita F (2014) Drug abuse, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e3283641b3d, 15:7, (525-531), Online publication date: 1-Jul-2014.

Keen L, Pereira D and Latimer W (2014) Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2014.04.011, 140, (156-160), Online publication date: 1-Jul-2014.

Brust J (2014) Neurologic Complications of Illicit Drug Abuse, CONTINUUM: Lifelong Learning in Neurology, 10.1212/01.CON.0000450971.99322.cd, 20, (642-656), Online publication date: 1-Jun-2014.

Fitzcharles M, Clauw D, Ste‐Marie P and Shir Y (2014) The Dilemma of Medical Marijuana Use by Rheumatology Patients, Arthritis Care & Research, 10.1002/acr.22267, 66:6, (797-801), Online publication date: 1-Jun-2014.

Thankavel P, Mir A and Ramaciotti C (2013) Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen, Cardiology in the Young, 10.1017/S1047951113000231, 24:2, (283-289), Online publication date: 1-Apr-2014.

Hartung B, Kauferstein S, Ritz-Timme S and Daldrup T (2014) Sudden unexpected death under acute influence of cannabis, Forensic Science International, 10.1016/j.forsciint.2014.02.001, 237, (e11-e13), Online publication date: 1-Apr-2014.

Rezkalla S and Kloner R (2014) Recreational Marijuana Use: Is it Safe for Your Patient?, Journal of the American Heart Association, 3:2, Online publication date: 24-Mar-2014.

Jouanjus E, Lapeyre‐Mestre M and Micallef J (2014) Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders, Journal of the American Heart Association, 3:2, Online publication date: 24-Mar-2014.

Colombo A, Proietti R, Čulić V, Lipovetzky N, Viecca M and Danna P (2014) Triggers of acute myocardial infarction, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e3283641351, 15:1, (1-7), Online publication date: 1-Jan-2014.

Siddiqui T (2014) Recurrent myopericarditis as a complication of Marijuana use, American Journal of Case Reports, 10.12659/AJCR.889808, 15, (60-62)

Vidot D, Prado G, Hlaing W, Arheart K and Messiah S (2014) Emerging Issues for our Nation's Health: The Intersection of Marijuana Use and Cardiometabolic Disease Risk, Journal of Addictive Diseases, 10.1080/10550887.2014.882718, 33:1, (1-8), Online publication date: 1-Jan-2014.

Saxon A and Browne K (2014) Marijuana not ready for prime time as an analgesic, General Hospital Psychiatry, 10.1016/j.genhosppsych.2013.08.005, 36:1, (4-6), Online publication date: 1-Jan-2014.

Thomas G, Kloner R and Rezkalla S (2014) Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know, The American Journal of Cardiology, 10.1016/j.amjcard.2013.09.042, 113:1, (187-190), Online publication date: 1-Jan-2014.

Fuster D, Cheng D, Allensworth-Davies D, Palfai T, Samet J and Saitz R (2013) No Detectable Association Between Frequency of Marijuana Use and Health or Healthcare Utilization Among Primary Care Patients Who Screen Positive for Drug Use, Journal of General Internal Medicine, 10.1007/s11606-013-2605-z, 29:1, (133-139), Online publication date: 1-Jan-2014.

Cadet J, Bisagno V and Milroy C (2013) Neuropathology of substance use disorders, Acta Neuropathologica, 10.1007/s00401-013-1221-7, 127:1, (91-107), Online publication date: 1-Jan-2014.

Hall W and Degenhardt L (2013) The adverse health effects of chronic cannabis use, Drug Testing and Analysis, 10.1002/dta.1506, 6:1-2, (39-45), Online publication date: 1-Jan-2014.

Quraishi R, Jain R, Chatterjee B and Verma A (2013) Laboratory Profiles of Treatment-Seeking Subjects With Concurrent Dependence on Cannabis and Other Substances: A Comparative Study, International Journal of High Risk Behaviors and Addiction, 10.5812/ijhrba.10993, 2:3, (107-111)

Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik J and Levine J (2013) Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 10.1097/01.MIB.0000435851.94391.37, 19:13, (2809-2814), Online publication date: 1-Dec-2013.

Ghannem M, Belhadj I, Tritar A, Moukala T, Amri N, Noury A and Zaghdoudi M (2013) Cannabis et syndromes coronariens aigus avec sus-décalage de ST, Annales de Cardiologie et d'Angéiologie, 10.1016/j.ancard.2013.09.002, 62:6, (424-428), Online publication date: 1-Dec-2013.

Gordon A, Conley J and Gordon J (2013) Medical Consequences of Marijuana Use: A Review of Current Literature, Current Psychiatry Reports, 10.1007/s11920-013-0419-7, 15:12, Online publication date: 1-Dec-2013.

Peters A, von Klot S, Mittleman M, Meisinger C, Hörmann A, Kuch B and Wichmann H (2012) Triggering of acute myocardial infarction by different means of transportation, European Journal of Preventive Cardiology, 10.1177/2047487312446672, 20:5, (750-758), Online publication date: 1-Oct-2013.

Khouzam R, Kabra R and Soufi M (2013) Marijuana, bigeminal premature ventricular contractions and sluggish coronary flow: Are they related?, Journal of Cardiology Cases, 10.1016/j.jccase.2013.06.006, 8:4, (121-124), Online publication date: 1-Oct-2013.

Desbois A and Cacoub P (2013) Cannabis-Associated Arterial Disease, Annals of Vascular Surgery, 10.1016/j.avsg.2013.01.002, 27:7, (996-1005), Online publication date: 1-Oct-2013.

Nawrot T, Cox B, Janssen B and Plusquin M (2013) Prevention – Passive smoking and pregnancy, European Journal of Cancer Supplements, 10.1016/j.ejcsup.2013.07.003, 11:2, (242-247), Online publication date: 1-Sep-2013.

Hill K, Bennett H, Griffin M, Connery H, Fitzmaurice G, Subramaniam G, Woody G and Weiss R (2013) Association of cannabis use with opioid outcomes among opioid-dependent youth, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2013.02.030, 132:1-2, (342-345), Online publication date: 1-Sep-2013.

Barber P, Pridmore H, Krishnamurthy V, Roberts S, Spriggs D, Carter K and Anderson N (2013) Cannabis, Ischemic Stroke, and Transient Ischemic Attack, Stroke, 44:8, (2327-2329), Online publication date: 1-Aug-2013.

Pacher P and Kunos G (2013) Modulating the endocannabinoid system in human health and disease – successes and failures, The FEBS Journal, 10.1111/febs.12260, 280:9, (1918-1943), Online publication date: 1-May-2013.

Katsiki N, Papadopoulou S, Fachantidou A and Mikhailidis D (2013) Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease?, Public Health, 10.1016/j.puhe.2012.12.021, 127:5, (435-441), Online publication date: 1-May-2013.

Wolff V, Armspach J, Lauer V, Rouyer O, Bataillard M, Marescaux C and Geny B (2012) Cannabis-related Stroke, Stroke, 44:2, (558-563), Online publication date: 1-Feb-2013.

Frost L, Mostofsky E, Rosenbloom J, Mukamal K and Mittleman M (2013) Marijuana use and long-term mortality among survivors of acute myocardial infarction, American Heart Journal, 10.1016/j.ahj.2012.11.007, 165:2, (170-175), Online publication date: 1-Feb-2013.

Muetzel R, Marjańska M, Collins P, Becker M, Valabrègue R, Auerbach E, Lim K and Luciana M (2013) In vivo 1H magnetic resonance spectroscopy in young-adult daily marijuana users, NeuroImage: Clinical, 10.1016/j.nicl.2013.04.011, 2, (581-589), .

Fischer B, Dawe M, McGuire F, Shuper P, Capler R, Bilsker D, Jones W, Taylor B, Rudzinski K and Rehm J (2013) Feasibility and impact of brief interventions for frequent cannabis users in Canada, Journal of Substance Abuse Treatment, 10.1016/j.jsat.2012.03.006, 44:1, (132-138), Online publication date: 1-Jan-2013.

Filali T, Lahidheb D, Gommidh M, Jdaida B, Hajlaoui N, Fehri W and Haouala H (2013) Spontaneous multivessel coronary artery dissection associated with cannabis use, Journal of Cardiology Cases, 10.1016/j.jccase.2012.08.002, 7:1, (e4-e7), Online publication date: 1-Jan-2013.

Purushottam B and Figueredo V (2013) Sudden Cardiac Death and Addictive Chemical Substances Electrical Diseases of the Heart, 10.1007/978-1-4471-4978-1_28, (441-460), .

Norberg M, Gates P, Dillon P, Kavanagh D, Manocha R and Copeland J (2012) Screening and managing cannabis use: comparing GP’s and nurses’ knowledge, beliefs, and behavior, Substance Abuse Treatment, Prevention, and Policy, 10.1186/1747-597X-7-31, 7:1, Online publication date: 1-Dec-2012.

Tormey W (2012) Cannabis, possible cardiac deaths and the coroner in Ireland, Irish Journal of Medical Science, 10.1007/s11845-011-0802-5, 181:4, (479-482), Online publication date: 1-Dec-2012.

Brookhart M, Walker A, Lu Y, Polakowski L, Li J, Paeglow C, Puenpatom T, Izurieta H and Daniel G (2012) Characterizing Vaccine-associated Risks Using Cubic Smoothing Splines, American Journal of Epidemiology, 10.1093/aje/kws158, 176:10, (949-957), Online publication date: 15-Nov-2012.

Farooqi K, Sutton N, Weinstein S, Menegus M, Spindola-Franco H and Pass R (2012) Neonatal Myocardial Infarction: Case Report and Review of the Literature, Congenital Heart Disease, 10.1111/j.1747-0803.2012.00660.x, 7:6, (E97-E102), Online publication date: 1-Nov-2012.

Arora S, Goyal H, Aggarwal P and Kukar A (2012) ST-segment elevation myocardial infarction in a 37-year-old man with normal coronaries—it is not always cocaine!, The American Journal of Emergency Medicine, 10.1016/j.ajem.2011.12.033, 30:9, (2091.e3-2091.e5), Online publication date: 1-Nov-2012.

Heath T, Burroughs Z, Thompson A and Tecklenburg F (2012) Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents, The Journal of Pediatric Pharmacology and Therapeutics, 10.5863/1551-6776-17.2.177, 17:2, (177-181), Online publication date: 1-Oct-2012.

Tormey W (2012) Cannabis misinterpretation and misadventure in a coroner's court, Medicine, Science and the Law, 10.1258/msl.2011.011087, 52:4, (229-230), Online publication date: 1-Oct-2012.

Rudź R, Schlicker E, Baranowska U, Marciniak J, Karabowicz P and Malinowska B (2012) Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor, Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.112.196816, 343:1, (198-205), Online publication date: 1-Oct-2012.

Singh N, Pan Y, Muengtaweeponsa S, Geller T and Cruz-Flores S (2012) Cannabis-Related Stroke: Case Series and Review of Literature, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2010.12.010, 21:7, (555-560), Online publication date: 1-Oct-2012.

Faa A, Senes G, Locci A, Pampaloni P, Pais M, Piras B, d'Aloja E and Faa G (2012) S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker?, Clinics, 10.6061/clinics/2012(07)19, 67:7, (821-826), Online publication date: 1-Jul-2012.

Pratap B and Korniyenko A (2011) Toxic Effects of Marijuana on the Cardiovascular System, Cardiovascular Toxicology, 10.1007/s12012-011-9150-y, 12:2, (143-148), Online publication date: 1-Jun-2012.

Klee E, Schneider H, Clark K, Cousin M, Ebbert J, Hooten W, Karpyak V, Warner D and Ekker S (2011) Zebrafish: a model for the study of addiction genetics, Human Genetics, 10.1007/s00439-011-1128-0, 131:6, (977-1008), Online publication date: 1-Jun-2012.

Singla S, Sachdeva R and Mehta J (2012) Cannabinoids and Atherosclerotic Coronary Heart Disease, Clinical Cardiology, 10.1002/clc.21962, 35:6, (329-335), Online publication date: 1-Jun-2012.

Baek S and So W Association between weight status and recreational drug abuse in Korean adolescents, Open Medicine, 10.2478/s11536-011-0136-8, 7:2, (224-229)

Malinowska B, Baranowska‐Kuczko M and Schlicker E (2012) Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?, British Journal of Pharmacology, 10.1111/j.1476-5381.2011.01747.x, 165:7, (2073-2088), Online publication date: 1-Apr-2012.

(2012) Marijuana ( Cannabis sativa L.) and Synthetic Cannabinoids Medical Toxicology of Drug Abuse, 10.1002/9781118105955.ch60, (886-931), Online publication date: 9-Mar-2012.

O'Brien M, Comment L, Liang K and Anthony J (2012) Does cannabis onset trigger cocaine onset? A case‐crossover approach, International Journal of Methods in Psychiatric Research, 10.1002/mpr.359, 21:1, (66-75), Online publication date: 1-Mar-2012.

Tormey W, Moore T and Gulmann C (2012) Cannabis smoking and myocardial infarction, International Journal of Clinical Practice, 10.1111/j.1742-1241.2011.02834.x, 66:2, (226-226), Online publication date: 1-Feb-2012.

Yurtdaş M and Aydın M (2012) Acute Myocardial Infarction in a Young Man; Fatal Blow of the Marijuana: A Case Report, Korean Circulation Journal, 10.4070/kcj.2012.42.9.641, 42:9, (641), .

SAFAA A, MARKHAM R and JAYASINGHE R (2011) Marijuana‐induced recurrent acute coronary syndrome with normal coronary angiograms, Drug and Alcohol Review, 10.1111/j.1465-3362.2011.00327.x, 31:1, (91-94), Online publication date: 1-Jan-2012.

Barbieux M, Véran O and Detante O (2012) Accidents vasculaires cérébraux ischémiques du sujet jeune et toxiques, La Revue de Médecine Interne, 10.1016/j.revmed.2011.04.008, 33:1, (35-40), Online publication date: 1-Jan-2012.

Renard D, Taieb G, Gras-Combe G and Labauge P (2012) Cannabis-Related Myocardial Infarction and Cardioembolic Stroke, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2010.04.002, 21:1, (82-83), Online publication date: 1-Jan-2012.

Mura P and Dumestre-Toulet V (2012) Cannabis sativa variété indica Traité De Toxicologie Médico-judiciaire, 10.1016/B978-2-294-71561-7.00011-X, (299-320), .

Tormey W and Moore T (2011) Inconsistent coroner interpretations of cardiac death in the presence of cannabis in urine, Forensic Toxicology, 10.1007/s11419-011-0122-5, 30:1, (84-85), Online publication date: 1-Jan-2012.

Furlanello F, Serdoz L, De Ambroggi L and Cappato R (2012) Drug Abuse in Cardiovascular Diseases Drug Abuse and Addiction in Medical Illness, 10.1007/978-1-4614-3375-0_32, (393-406), .

Mir A, Obafemi A, Young A and Kane C (2011) Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2, Pediatrics, 10.1542/peds.2010-3823, 128:6, (e1622-e1627), Online publication date: 1-Dec-2011.

Franklin B and Lavie C (2015) Triggers of Acute Cardiovascular Events and Potential Preventive Strategies: Prophylactic Role of Regular Exercise, The Physician and Sportsmedicine, 10.3810/psm.2011.11.1934, 39:4, (11-21), Online publication date: 1-Nov-2011.

Janero D, Lindsley L, Vemuri V and Makriyannis A (2011) Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk, Expert Opinion on Drug Discovery, 10.1517/17460441.2011.608063, 6:10, (995-1025), Online publication date: 1-Oct-2011.

Fischer B, Jeffries V, Hall W, Room R, Goldner E and Rehm J (2011) Lower Risk Cannabis Use Guidelines for Canada (LRCUG): A Narrative Review of Evidence and Recommendations, Canadian Journal of Public Health, 10.1007/BF03404169, 102:5, (324-327), Online publication date: 1-Sep-2011.

Esse K, Fossati‐Bellani M, Traylor A and Martin‐Schild S (2011) Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard, Brain and Behavior, 10.1002/brb3.7, 1:1, (44-54), Online publication date: 1-Sep-2011.

Jouanjus E, Leymarie F, Tubery M and Lapeyre‐Mestre M (2011) Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2010.03897.x, 71:5, (758-765), Online publication date: 1-May-2011.

Munters E and Nawrot T (2011) An Epidemiological Appraisal of Smoking‐Related Outcomes Cigarette Smoke Toxicity, 10.1002/9783527635320.ch6, (93-120), Online publication date: 23-Feb-2011.

Durst R and Lotan C (2010) The Potential for Clinical Use of Cannabinoids in Treatment of Cardiovascular Diseases, Cardiovascular Therapeutics, 10.1111/j.1755-5922.2010.00233.x, 29:1, (17-22), Online publication date: 1-Feb-2011.

Nawrot T, Perez L, Künzli N, Munters E and Nemery B (2011) Public health importance of triggers of myocardial infarction: a comparative risk assessment, The Lancet, 10.1016/S0140-6736(10)62296-9, 377:9767, (732-740), Online publication date: 1-Feb-2011.

Berg C, Buchanan T, Grimsley L, Rodd J and Smith D (2011) Personality characteristics and health risk behaviors associated with current marijuana use among college students, Open Journal of Preventive Medicine, 10.4236/ojpm.2011.13015, 01:03, (101-108), .

De Silva K and Perera D (2011) Cannabis, Collaterals, and Coronary Occlusion, Case Reports in Cardiology, 10.1155/2011/469850, 2011, (1-3), .

Shrey K, Suchit A, Deepika D, Shruti K and Vibha R (2011) Air pollutants: The key stages in the pathway towards the development of cardiovascular disorders, Environmental Toxicology and Pharmacology, 10.1016/j.etap.2010.09.002, 31:1, (1-9), Online publication date: 1-Jan-2011.

Brust J (2011) Stroke and Substance Abuse Stroke, 10.1016/B978-1-4160-5478-8.10042-9, (790-813), .

Tofler G, O’Farrell A and Buckley T (2011) Psychological Triggers for Plaque Rupture Stress and Cardiovascular Disease, 10.1007/978-1-84882-419-5_9, (151-168), .

Hayatbakhsh M, O'Callaghan M, Mamun A, Williams G, Clavarino A and Najman J (2010) Cannabis Use and Obesity and Young Adults, The American Journal of Drug and Alcohol Abuse, 10.3109/00952990.2010.500438, 36:6, (350-356), Online publication date: 1-Nov-2010.

Weaver M (2010) Medical sequelae of addiction Clinical Addiction Psychiatry, 10.1017/CBO9780511782107.004, (24-36)

Hoffman J (2010) The Psychedelic 1960s, Hippies in Their 60s: Substance Abuse in the Elderly, The Consultant Pharmacist, 10.4140/TCP.n.2010.570, 25:9, (570-576), Online publication date: 1-Sep-2010.

Gradman A and Javed N (2010) Addictive Disorders in Cardiovascular Medicine Addictive Disorders in Medical Populations, 10.1002/9780470710449.ch17, (251-275), Online publication date: 27-Aug-2010.

Bailly C, Merceron O, Hammoudi N, Dorent R and Michel P (2010) Cannabis induced acute coronary syndrome in a young female, International Journal of Cardiology, 10.1016/j.ijcard.2008.11.200, 143:1, (e4-e6), Online publication date: 1-Aug-2010.

Schwartz B, Mayeda G, Burstein S, Economides C and Kloner R (2015) When and Why Do Heart Attacks Occur? Cardiovascular Triggers and Their Potential Role, Hospital Practice, 10.3810/hp.2010.06.308, 38:3, (144-152), Online publication date: 1-Jun-2010.

Lopez-Quintero C and Neumark Y (2010) Effects of risk perception of marijuana use on marijuana use and intentions to use among adolescents in Bogotá, Colombia, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2009.12.011, 109:1-3, (65-72), Online publication date: 1-Jun-2010.

Stoové M and Dietze P (2010) Epidemiology Addiction Research Methods, 10.1002/9781444318852.ch19, (299-318), Online publication date: 2-Apr-2010.

Duchene C, Olindo S, Chausson N, Jeannin S, Cohen-Tenoudji P and Smadja D (2010) Infarctus cérébral et myocardique après consommation de cannabis chez une femme jeune, Revue Neurologique, 10.1016/j.neurol.2009.10.006, 166:4, (438-442), Online publication date: 1-Apr-2010.

Han B, Gfroerer J and Colliver J (2010) Associations Between Duration of Illicit Drug Use and Health Conditions: Results from the 2005–2007 National Surveys on Drug Use and Health, Annals of Epidemiology, 10.1016/j.annepidem.2010.01.003, 20:4, (289-297), Online publication date: 1-Apr-2010.

Ehlers C, Gizer I, Vieten C and Wilhelmsen K (2009) Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 10.1002/ajmg.b.31050, 153B:3, (802-811), Online publication date: 1-Apr-2010.

Goldman M, Suh J, Lynch K, Szucs R, Ross J, Xie H, O'Brien C and Oslin D (2010) Identifying Risk Factors for Marijuana Use Among Veterans Affairs Patients, Journal of Addiction Medicine, 10.1097/ADM.0b013e3181b18782, 4:1, (47-51), Online publication date: 1-Mar-2010.

Ehlers C, Gizer I, Vieten C, Gilder D, Stouffer G, Lau P and Wilhelmsen K (2010) Cannabis dependence in the San Francisco Family Study: Age of onset of use, DSM-IV symptoms, withdrawal, and heritability, Addictive Behaviors, 10.1016/j.addbeh.2009.09.009, 35:2, (102-110), Online publication date: 1-Feb-2010.

Wayangankar S, Dasari T, Lozano P and Beckman K (2010) A Case of Critical Aortic Stenosis Masquerading as Acute Coronary Syndrome, Cardiology Research and Practice, 10.4061/2010/423465, 2010, (1-4), .

Tormey W (2010) Adverse health effects of non-medical cannabis use, The Lancet, 10.1016/S0140-6736(10)60086-4, 375:9710, (196), Online publication date: 1-Jan-2010.

Sattout A and Nicol M (2009) Cardiac arrest following cannabis use: a case report, Cases Journal, 10.1186/1757-1626-2-208, 2:1, Online publication date: 1-Dec-2009.

Cinti S (2009) Medical Marijuana in HIV-Positive Patients: What Do We Know?, Journal of the International Association of Physicians in AIDS Care, 10.1177/1545109709351167, 8:6, (342-346), Online publication date: 1-Nov-2009.

Hill S and Thomas S (2009) What's new in… Toxicity of drugs of abuse, Medicine, 10.1016/j.mpmed.2009.08.009, 37:11, (621-626), Online publication date: 1-Nov-2009.

Hall W (2009) The adverse health effects of cannabis use: What are they, and what are their implications for policy?, International Journal of Drug Policy, 10.1016/j.drugpo.2009.02.013, 20:6, (458-466), Online publication date: 1-Nov-2009.

Cappelli F, Valente S and Gensini G (2009) Is it time to consider cannabis smoking a cardiovascular risk factor?, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e32832e19b9, 10:10, (745-746), Online publication date: 1-Oct-2009.

Hall W and Degenhardt L (2009) Adverse health effects of non-medical cannabis use, The Lancet, 10.1016/S0140-6736(09)61037-0, 374:9698, (1383-1391), Online publication date: 1-Oct-2009.

Pujazon-Zazik M and Park M (2009) Marijuana: Use Among Young Males and Health Outcomes, American Journal of Men's Health, 10.1177/1557988309340577, 3:3, (265-274), Online publication date: 1-Sep-2009.

Ehlers C, Gilder D, Gizer I and Wilhelmsen K (2009) GENETIC STUDY: Heritability and a genome‐wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community, Addiction Biology, 10.1111/j.1369-1600.2009.00160.x, 14:3, (338-348), Online publication date: 1-Jul-2009.

Reece A (2009) Chronic toxicology of cannabis, Clinical Toxicology, 10.1080/15563650903074507, 47:6, (517-524), Online publication date: 1-Jul-2009.

Basnet S, Mander G and Nicolas R (2009) Coronary Vasospasm in an Adolescent Resulting from Marijuana Use, Pediatric Cardiology, 10.1007/s00246-009-9384-7, 30:4, (543-545), Online publication date: 1-May-2009.

Hiley C (2009) Endocannabinoids and the Heart, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e318192671d, 53:4, (267-276), Online publication date: 1-Apr-2009.

Richiardi L, Vizzini L, Merletti F and Barone-Adesi F (2009) Cardiovascular benefits of smoking regulations: The effect of decreased exposure to passive smoking, Preventive Medicine, 10.1016/j.ypmed.2008.11.013, 48:2, (167-172), Online publication date: 1-Feb-2009.

Shah P (2008) Inflammation and Plaque Vulnerability, Cardiovascular Drugs and Therapy, 10.1007/s10557-008-6147-2, 23:1, (31-40), Online publication date: 1-Feb-2009.

(2009) Compounds found in Herbal products Meyler's Side Effects of Herbal Medicines, 10.1016/B978-0-444-53269-5.50006-6, (237-296), .

(2009) ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS MeylerÃ¢Â€Â™s Side Effects of Cardiovascular Drugs, 10.1016/B978-0-444-53268-8.50009-0, (557-820), .

(2009) DRUGS OF ABUSE Meyler's Side Effects of Psychiatric Drugs, 10.1016/B978-0-444-53266-4.50007-0, (451-628), .

Khiabani H, Mørland J and Bramness J (2008) Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis, European Journal of Internal Medicine, 10.1016/j.ejim.2007.06.031, 19:8, (608-612), Online publication date: 1-Dec-2008.

Safaei N (2008) Outcomes of Coronary Artery Bypass Grafting in Patients with a History of Opiate Use, Pakistan Journal of Biological Sciences, 10.3923/pjbs.2008.2594.2598, 11:22, (2594-2598), Online publication date: 1-Nov-2008.

Mushtaq F, Mondelli V and Pariante C (2011) The metabolic implications of long term cannabis use in patients with psychosis, Epidemiologia e Psichiatria Sociale, 10.1017/S1121189X00001317, 17:3, (221-226), Online publication date: 1-Sep-2008.

Cappelli F, Lazzeri C, Gensini G and Valente S (2008) Cannabis: a trigger for acute myocardial infarction? A case report, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e3282f2cd0d, 9:7, (725-728), Online publication date: 1-Jul-2008.

Ki M (2008) Theory and practice of Case-Crossover Study Design., Korean Journal of Epidemiology, 10.4178/kje.2008.30.1.1, 30:1, (1-11)

Rallidis L, Panagiotakos D, Pitsavos C, Stefanadis C and Kremastinos D (2008) Contribution of illicit drug addiction to acute myocardial infarction among youngsters, International Journal of Cardiology, 10.1016/j.ijcard.2007.04.094, 126:2, (286-287), Online publication date: 1-May-2008.

Amin S and Shah P (2008) Pathophysiology of Myocardial Infarction Reperfusion Therapy for Acute Myocardial Infarction, 10.3109/9781420019179.002, (15-28), Online publication date: 1-Mar-2008.

Boden W, Shah P, Gupta V and Ohman E (2008) Contemporary Approach to the Diagnosis and Management of Non–ST-Segment Elevation Acute Coronary Syndromes, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2007.11.003, 50:5, (311-351), Online publication date: 1-Mar-2008.

Gaziano J (2008) Marijuana use among those at risk for cardiovascular events, American Heart Journal, 10.1016/j.ahj.2007.12.016, 155:3, (395-396), Online publication date: 1-Mar-2008.

Mukamal K, Maclure M, Muller J and Mittleman M (2008) An exploratory prospective study of marijuana use and mortality following acute myocardial infarction, American Heart Journal, 10.1016/j.ahj.2007.10.049, 155:3, (465-470), Online publication date: 1-Mar-2008.

Korantzopoulos P, Liu T, Papaioannides D, Li G and Goudevenos J (2007) Atrial fibrillation and marijuana smoking, International Journal of Clinical Practice, 10.1111/j.1742-1241.2007.01505.x, 62:2, (308-313)

Giroud C, Bollmann M, Thomas A, Mangin P and Favrat B (2009) Consommation de cannabis: quels sont les risques ?, Annales de Toxicologie Analytique, 10.1051/ata/2009021, 20:4, (183-205), .

Mach F, Montecucco F and Steffens S (2009) Cannabinoid receptors in acute and chronic complications of atherosclerosis, British Journal of Pharmacology, 10.1038/sj.bjp.0707517, 153:2, (290-298), Online publication date: 1-Jan-2008.

Eftekhari H, Bukharovich I, Aziz E and Hong M (2008) Epidemiology and Pathophysiology of Acute Coronary Syndrome Acute Coronary Syndrome, 10.1007/978-1-84628-869-2_4, (25-36), .

Randall M (2009) Endocannabinoids and the haematological system, British Journal of Pharmacology, 10.1038/sj.bjp.0707420, 152:5, (671-675), Online publication date: 1-Nov-2007.

Shah P (2007) Molecular mechanisms of plaque instability, Current Opinion in Lipidology, 10.1097/MOL.0b013e3282efa326, 18:5, (492-499), Online publication date: 1-Oct-2007.

Gilder D, Lau P, Corey L and Ehlers C (2007) Factors Associated with Remission from Cannabis Dependence in Southwest California Indians, Journal of Addictive Diseases, 10.1300/J069v26n04_04, 26:4, (23-30), Online publication date: 27-Aug-2007.

Grotenhermen F (2007) The Toxicology of Cannabis and Cannabis Prohibition, Chemistry & Biodiversity, 10.1002/cbdv.200790151, 4:8, (1744-1769), Online publication date: 1-Aug-2007.

Müller-Nordhorn J and Willich S (2007) External triggers of onset of myocardial infarction – an update, Biological Rhythm Research, 10.1080/09291010600906182, 38:3, (217-232), Online publication date: 1-Jun-2007.

Seamon M, Fass J, Maniscalco-Feichtl M and Abu-Shraie N (2007) Medical marijuana and the developing role of the pharmacist, American Journal of Health-System Pharmacy, 10.2146/ajhp060471, 64:10, (1037-1044), Online publication date: 15-May-2007.

Aryana A and Williams M (2007) Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty?, International Journal of Cardiology, 10.1016/j.ijcard.2006.08.001, 118:2, (141-144), Online publication date: 1-May-2007.

Čulić V (2007) Acute risk factors for myocardial infarction, International Journal of Cardiology, 10.1016/j.ijcard.2006.05.011, 117:2, (260-269), Online publication date: 1-Apr-2007.

Bhattacharyya M and Steptoe A (2007) Emotional Triggers of Acute Coronary Syndromes: Strength of Evidence, Biological Processes, and Clinical Implications, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2006.11.002, 49:5, (353-365), Online publication date: 1-Mar-2007.

Ornato J, Muller J, Froelicher E and Kloner R (2007) Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.01.020, 49:12, (1389-1397), Online publication date: 1-Mar-2007.

Drolet B, Simard C and Poirier P (2007) Impact of Weight-Loss Medications on the Cardiovascular System, American Journal of Cardiovascular Drugs, 10.2165/00129784-200707040-00005, 7:4, (273-288), .

Ting J (2008) Letter to the Editor: “Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult”, Clinical Toxicology, 10.1080/15563650601073587, 45:4, (432-434), Online publication date: 1-Jan-2007.

Starcevic B and Sicaja M (2007) Dual intoxication with diazepam and amphetamine: This drug interaction probably potentiates myocardial ischemia, Medical Hypotheses, 10.1016/j.mehy.2006.12.033, 69:2, (377-380), Online publication date: 1-Jan-2007.

Brust J (2007) Cannabis Aspects neurologiques de l'addiction, 10.1016/B978-2-84299-712-0.50007-3, (273-314), .

DELGADO J (2007) Marijuana Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, 10.1016/B978-0-7216-0693-4.50046-3, (747-754), .

Karch S Postmortem Considerations Marijuana and the Cannabinoids, 10.1007/978-1-59259-947-9_13, (295-301)

Siscovick D (2006) Triggers of Clinical Coronary Heart Disease, Epidemiology, 10.1097/01.ede.0000231372.34197.2a, 17:5, (495-497), Online publication date: 1-Sep-2006.

Robert Segarra A, Torres Giménez A, Tejero Pociello A, Campo López C and Pérez de los Cobos J (2006) Efectos esperados y adversos del consumo de cannabis en sujetos dependientes de los tetrahidrocannabinoides, Trastornos Adictivos, 10.1016/S1575-0973(06)75115-7, 8:3, (148-154), Online publication date: 1-Sep-2006.

Rodondi N, Pletcher M, Liu K, Hulley S and Sidney S (2006) Marijuana Use, Diet, Body Mass Index, and Cardiovascular Risk Factors (from the CARDIA Study), The American Journal of Cardiology, 10.1016/j.amjcard.2006.03.024, 98:4, (478-484), Online publication date: 1-Aug-2006.

Tarín-Vicente N, Hernández-Rivas J, Cristóbal-Varela C and Alonso-Martín J (2006) Ictus isquémico tras infarto de miocardio fibrinolisado en paciente con hipercoagulabilidad, Revista Española de Cardiología, 10.1157/13087906, 59:5, (515-516), Online publication date: 1-May-2006.

Tarín-Vicente N, Hernández-Rivas J, Cristóbal-Varela C and Alonso-Martin J (2006) Ischemic Stroke After Fibrynolitic Therapy Myocardial Infarction in a Patient With Hypercoagulability, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(06)60802-5, 59:5, (515-516), Online publication date: 1-May-2006.

Ayala T and Schulman S (2006) Pathogenesis and Early Management of Non–ST-segment Elevation Acute Coronary Syndromes, Cardiology Clinics, 10.1016/j.ccl.2005.09.006, 24:1, (19-35), Online publication date: 1-Feb-2006.

Steffens S and Mach F (2006) Towards a therapeutic use of selective CB 2 cannabinoid receptor ligands for atherosclerosis , Future Cardiology, 10.2217/14796678.2.1.49, 2:1, (49-53), Online publication date: 1-Jan-2006.

Mach F (2008) New anti-inflammatory agents to reduce atherosclerosis, Archives of Physiology and Biochemistry, 10.1080/13813450600736026, 112:2, (130-137), Online publication date: 1-Jan-2006.

Steffens S and Mach F (2006) Vers un usage thérapeutique de ligands sélectifs du récepteur cannabinoïde 2 dans l’athérosclérose, médecine/sciences, 10.1051/medsci/20062217, 22:1, (7-9), Online publication date: 1-Jan-2006.

(2006) Cannabinoids Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 10.1016/B0-44-451005-2/00081-4, (614-624), .

Caldicott D, Holmes J, Roberts-Thomson K and Mahar L (2005) Keep off the grass: marijuana use and acute cardiovascular events, European Journal of Emergency Medicine, 10.1097/00063110-200510000-00008, 12:5, (236-244), Online publication date: 1-Oct-2005.

Lindsay A, Foale R, Warren O and Henry J (2005) Cannabis as a precipitant of cardiovascular emergencies, International Journal of Cardiology, 10.1016/j.ijcard.2004.10.038, 104:2, (230-232), Online publication date: 1-Sep-2005.

Rich D, Schwartz J, Mittleman M, Link M, Luttmann-Gibson H, Catalano P, Speizer F and Dockery D (2005) Association of Short-term Ambient Air Pollution Concentrations and Ventricular Arrhythmias, American Journal of Epidemiology, 10.1093/aje/kwi143, 161:12, (1123-1132), Online publication date: 15-Jun-2005.

El-Menyar A, El-Tawil M and Al Suwaidi J (2005) A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation, European Journal of Emergency Medicine, 10.1097/00063110-200506000-00009, 12:3, (137-141), Online publication date: 1-Jun-2005.

Pijlman F, Rigter S, Hoek J, Goldschmidt H and Niesink R (2006) Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops, Addiction Biology, 10.1080/13556210500123217, 10:2, (171-180), Online publication date: 1-Jun-2005.

de Jong F, Engels F, Mathijssen R, van Zuylen L, Verweij J, Peters R and Sparreboom A (2005) Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?, Journal of Clinical Oncology, 10.1200/JCO.2005.04.150, 23:13, (2886-2891), Online publication date: 1-May-2005.

Dietze P, Jolley D, Fry C and Bammer G (2005) Transient changes in behaviour lead to heroin overdose: results from a case‐crossover study of non‐fatal overdose, Addiction, 10.1111/j.1360-0443.2005.01051.x, 100:5, (636-642), Online publication date: 1-May-2005.

Roth M (2005) Marijuana and your heart, Nature, 10.1038/434708a, 434:7034, (708-709), Online publication date: 1-Apr-2005.

Clough A (2005) Associations between tobacco and cannabis use in remote indigenous populations in Northern Australia, Addiction, 10.1111/j.1360-0443.2005.01040.x, 100:3, (346-353), Online publication date: 1-Mar-2005.

Čulić V, Eterović D and Mirić D (2005) Meta-analysis of possible external triggers of acute myocardial infarction, International Journal of Cardiology, 10.1016/j.ijcard.2004.01.008, 99:1, (1-8), Online publication date: 1-Mar-2005.

Robson P Human Studies of Cannabinoids and Medicinal Cannabis Cannabinoids, 10.1007/3-540-26573-2_25, (719-756)

Shah P (2004) Cellular and Molecular Mechanisms of Plaque Rupture High-Risk Atherosclerotic Plaques, 10.1201/9781420037883.ch1, (1-17), Online publication date: 20-Dec-2004.

Peters A, von Klot S, Heier M, Trentinaglia I, Hörmann A, Wichmann H and Löwel H (2004) Exposure to Traffic and the Onset of Myocardial Infarction, New England Journal of Medicine, 10.1056/NEJMoa040203, 351:17, (1721-1730), Online publication date: 21-Oct-2004.

Deusch E, Kress H, Kraft B and Kozek-Langenecker S (2004) The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets, Anesthesia & Analgesia, 10.1213/01.ANE.0000131505.03006.74, 99:4, (1127-1130), Online publication date: 1-Oct-2004.

Kalant H (2004) Adverse effects of cannabis on health: an update of the literature since 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2004.05.027, 28:5, (849-863), Online publication date: 1-Aug-2004.

Notcutt W, Price M, Miller R, Newport S, Phillips C, Simmons S and Sansom C (2004) Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies, Anaesthesia, 10.1111/j.1365-2044.2004.03674.x, 59:5, (440-452), Online publication date: 1-May-2004.

Schlaerth K, Splawn R, Ong J and Smith S (2004) Change in the Pattern of Illegal Drug Use in an Inner City Population Over 50, Journal of Addictive Diseases, 10.1300/J069v23n02_07, 23:2, (95-107), Online publication date: 14-Apr-2004.

Roberts B and Bogg T (2004) A Longitudinal Study of the Relationships Between Conscientiousness and the Social‐ Environmental Factors and Substance‐Use Behaviors That Influence Health, Journal of Personality, 10.1111/j.0022-3506.2004.00264.x, 72:2, (325-354), Online publication date: 1-Apr-2004.

Grotenhermen F (2004) Clinical Pharmacodynamics of Cannabinoids, Journal of Cannabis Therapeutics, 10.1300/J175v04n01_03, 4:1, (29-78), Online publication date: 26-Feb-2004.

Hiley C and Ford W (2007) Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling, Biological Reviews, 10.1017/S1464793103006201, 79:1, (187-205), Online publication date: 1-Feb-2004.

Russo E (2004) Introduction: Cannabis: From Pariah to Prescription, Journal of Cannabis Therapeutics, 10.1300/J175v03n03_01, 3:3, (1-29), Online publication date: 5-Jan-2004.

Moussouttas M (2004) Cannabis Use and Cerebrovascular Disease, The Neurologist, 10.1097/01.nrl.0000107493.19282.b0, 10:1, (47-53), Online publication date: 1-Jan-2004.

Brust J (2004) Marijuana Neurological Aspects of Substance Abuse, 10.1016/B978-0-7506-7313-6.50011-8, (225-258), .

Rezkalla S, Sharma P and Kloner R (2003) Coronary no-flow and ventricular tachycardia associated with habitual marijuana use, Annals of Emergency Medicine, 10.1016/S0196-0644(03)00426-8, 42:3, (365-369), Online publication date: 1-Sep-2003.

Misra P, Caldito G, Kakkar A, Mancini M and Reddy P (2003) Outcomes of coronary artery bypass grafting in patients with a history of illicit drug use, The American Journal of Cardiology, 10.1016/S0002-9149(03)00730-6, 92:5, (593-595), Online publication date: 1-Sep-2003.

Shah P (2003) Pathophysiology of plaque rupture and the concept of plaque stabilization, Cardiology Clinics, 10.1016/S0733-8651(03)00058-4, 21:3, (303-314), Online publication date: 1-Aug-2003.

Frishman W, Del Vecchio A, Sanal S and Ismail A (2003) Cardiovascular Manifestations of Substance Abuse, Heart Disease, 10.1097/01.hdx.0000080713.09303.a6, 5:4, (253-271), Online publication date: 1-Jul-2003.

Walker I (2003) Arterial thromboembolism in pregnancy, Best Practice & Research Clinical Haematology, 10.1016/S1521-6926(02)00100-7, 16:2, (297-310), Online publication date: 1-Jun-2003.

Wagner J, Hu K, Karcher J, Bauersachs J, Schäfer A, Laser M, Han H and Ertl G (2009) CB 1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction , British Journal of Pharmacology, 10.1038/sj.bjp.0705156, 138:7, (1251-1258), Online publication date: 1-Apr-2003.

Mathre M (2003) Cannabis series ‐ the whole story Part 6: Potential risks related to acute and chronic use of cannabis, Drugs and Alcohol Today, 10.1108/17459265200300002, 3:1, (3-6), Online publication date: 1-Mar-2003.

Shah P (2003) Mechanisms of plaque vulnerability and rupture, Journal of the American College of Cardiology, 10.1016/S0735-1097(02)02834-6, 41:4, (S15-S22), Online publication date: 1-Feb-2003.

Grotenhermen F (2003) Clinical Pharmacokinetics of Cannabinoids, Journal of Cannabis Therapeutics, 10.1300/J175v03n01_02, 3:1, (3-51), Online publication date: 29-Jan-2003.

Grotenhermen F (2003) Pharmacokinetics and Pharmacodynamics of Cannabinoids, Clinical Pharmacokinetics, 10.2165/00003088-200342040-00003, 42:4, (327-360), .

Wong E and Patel J (2003) Drugs of abuse , 10.1016/S0378-6080(03)80011-9, (30-45), .

Sidney S (2014) Cardiovascular Consequences of Marijuana Use, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.2002.tb06005.x, 42:S1, Online publication date: 1-Nov-2002.

Jones R (2014) Cardiovascular System Effects of Marijuana, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.2002.tb06004.x, 42:S1, Online publication date: 1-Nov-2002.

Petro D (2002) Cannabis in Multiple Sclerosis: Women's Health Concerns, Journal of Cannabis Therapeutics, 10.1300/J175v02n03_12, 2:3-4, (161-175), Online publication date: 1-Jun-2002.

Shah P (2002) Pathophysiology of coronary thrombosis: Role of plaque rupture and plaque erosion, Progress in Cardiovascular Diseases, 10.1053/pcad.2002.123473, 44:5, (357-368), Online publication date: 1-Mar-2002.

Servoss S, Januzzi J and Muller J (2002) Triggers of acute coronary syndromes, Progress in Cardiovascular Diseases, 10.1053/pcad.2002.123470, 44:5, (369-380), Online publication date: 1-Mar-2002.

(2010) Acupuncture, Focus on Alternative and Complementary Therapies, 10.1211/fact.2001.00309, 6:4, (285-285), Online publication date: 1-Dec-2001.

Allan R, Scheidt S and Smith C (2001) Coronary heart disease: cardiac psychology Cambridge Handbook of Psychology, Health and Medicine, 10.1017/CBO9780511543579.152, (648-653)

June 12, 2001
Vol 103, Issue 23

Article Information

Metrics

https://doi.org/10.1161/01.CIR.103.23.2805

Manuscript receivedSeptember 5, 2000
Manuscript acceptedApril 3, 2001
Originally publishedJune 12, 2001
Manuscript revisedApril 2, 2001

Keywords

PDF download

OpenAthens/Shibboleth »

Jump to

Triggering Myocardial Infarction by Marijuana